hg_145672.1

Basic information about the TSS

---

TSS ID: hg_145672.1 Species: human Chr: chr15		Start: 31339586 End: 31339608 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000560473.1 Distance: 325 GeneID: 51621 HGNC/MGI_ID: HGNC:13672 UniProt_ID: H0YK05

Gene_name: Kruppel like factor 13 Gene_symbol: KLF13 Gene_synonyms: BTEB3 FKLF-2 NSLP1 RFLAT-1 Gene_source: HGNC:13672

TATA-Box annotation

---

Distance to TSS:	12762
Nearest PromoterID:	NM_001302461
Entrez ID:	51621
Nearest Unigene:	Hs.376443
Nearest Refseq:	NM_015995
Nearest Ensembl:	ENSG00000169926
Gene Name:	Kruppel like factor 13
Gene Alias:	BTEB3|FKLF2|NSLP1|RFLAT-1|RFLAT1
Gene Description:	Kruppel like factor 13
Gene Type:	protein-coding
CpG%:	0.03
GC%:	0.557214
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@KLF13 p2@KLF13 p3@KLF13 p4@KLF13 p5@KLF13 p6@KLF13 p8@KLF13 p9@KLF13 p10@KLF13
Sample		p1@KLF13	p2@KLF13	p3@KLF13	p4@KLF13	p5@KLF13	p6@KLF13	p8@KLF13	p9@KLF13	p10@KLF13
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	9.93	2.34	0.97	0.00	0.00	0.19	0.58	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	11.53	1.62	0.20	0.00	0.00	0.00	0.40	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	12.92	2.31	0.77	0.00	0.00	0.19	0.39	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	6.86	1.66	0.83	0.00	0.00	0.00	0.42	0.42	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	11.92	1.57	0.45	0.00	0.00	0.22	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	8.53	2.33	0.58	0.00	0.00	0.00	0.00	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	3.27	0.65	0.22	0.00	0.00	0.22	0.87	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	4.84	0.73	0.73	0.00	0.00	0.00	0.24	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	4.49	0.85	0.85	0.00	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	2.32	0.00	0.58	0.00	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	3.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	0.81	1.22	0.81	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	6.61	2.10	1.45	0.00	0.00	0.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	3.31	1.20	1.05	0.00	0.15	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	3.95	1.54	1.32	0.00	0.00	0.00	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	5.53	1.51	2.01	0.00	0.25	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	3.71	0.87	1.09	0.00	0.00	0.00	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	5.06	2.11	1.69	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	4.80	3.20	2.13	0.00	0.53	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	5.42	2.11	0.75	0.00	0.30	0.00	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	4.41	2.00	1.47	0.00	0.27	0.00	0.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	6.04	2.07	1.04	0.00	0.00	0.00	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	4.39	2.84	0.90	0.13	0.26	0.26	0.00	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	5.82	2.18	1.70	0.00	0.00	0.49	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	4.13	2.06	0.77	0.00	0.26	0.00	0.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	6.33	2.53	1.90	0.00	0.00	0.00	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	4.95	2.20	0.55	0.00	0.00	0.55	0.00	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	5.42	3.06	1.18	0.00	0.47	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	4.36	1.78	0.81	0.00	0.16	0.00	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	4.89	2.53	1.27	0.00	0.36	0.00	0.18	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	5.02	1.05	1.05	0.00	0.00	0.00	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	3.91	2.54	1.37	0.00	0.20	0.00	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	3.80	1.27	0.63	0.00	0.42	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	2.80	1.81	0.16	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	5.24	2.06	0.19	0.00	0.00	0.00	0.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	4.22	1.53	0.57	0.00	0.38	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	3.68	0.61	0.41	0.00	0.00	0.20	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	5.64	1.21	0.81	0.00	0.40	0.00	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	4.05	0.54	1.08	0.00	0.27	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	3.36	1.20	0.96	0.00	0.00	0.00	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	4.47	1.65	0.71	0.00	0.00	0.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	2.34	1.02	0.29	0.00	0.15	0.15	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	3.37	1.27	0.84	0.00	0.00	0.21	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	2.80	1.57	1.22	0.00	0.17	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	1.61	1.41	1.61	0.00	0.00	0.20	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	2.09	0.47	0.47	0.00	0.00	0.00	0.23	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	2.88	1.44	0.96	0.00	0.24	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	2.38	1.49	0.60	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	4.31	3.35	0.96	0.00	0.00	0.00	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	3.24	1.82	1.42	0.00	0.20	0.40	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	3.48	1.02	1.64	0.00	0.00	0.20	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	3.34	0.89	1.56	0.00	0.00	0.00	0.67	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	4.61	2.13	0.35	0.00	0.00	0.00	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	2.98	2.32	0.33	0.00	0.00	0.33	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	3.36	0.00	0.00	0.00	0.00	0.00	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	0.46	0.46	0.46	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	4.21	1.62	0.65	0.00	0.00	0.00	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	4.50	3.21	0.96	0.00	0.00	0.00	0.96	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	3.77	0.63	0.31	0.00	0.00	0.00	1.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	2.82	3.53	0.00	0.00	0.00	0.00	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	5.05	1.12	1.12	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	4.78	0.80	0.80	0.00	0.80	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	5.10	1.36	0.68	0.00	0.00	0.00	0.34	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	7.80	2.27	0.65	0.00	0.32	0.32	0.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	9.23	2.84	0.00	0.00	0.71	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	9.26	6.83	1.46	0.00	0.00	0.49	0.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	8.93	2.98	0.00	0.00	0.00	0.00	0.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	7.51	5.16	0.00	0.00	0.94	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	3.31	2.65	0.00	0.00	0.00	0.00	0.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	5.88	2.47	0.31	0.00	0.00	0.00	1.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	5.81	5.20	0.31	0.00	0.00	0.00	0.61	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	30.88	17.90	3.64	1.11	2.53	1.74	0.79	1.11	1.43
Adipocyte - breast, donor2	11327-117E4	42.83	14.28	3.37	1.12	2.73	1.93	4.65	0.96	1.60
Adipocyte - omental, donor1	11473-119C6	27.10	15.01	3.82	1.53	3.05	1.53	1.02	0.51	1.27
Adipocyte - omental, donor2	11474-119C7	32.14	16.44	1.49	1.49	0.75	1.49	2.24	1.49	0.75
Adipocyte - omental, donor3	11475-119C8	25.79	9.71	3.68	1.34	1.34	1.00	1.00	0.33	0.33
Adipocyte - perirenal, donor1	11476-119C9	11.48	6.38	2.55	1.91	0.64	1.28	0.64	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	12.09	3.30	1.10	0.00	0.00	0.00	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	14.90	5.42	2.71	0.00	1.35	1.35	0.45	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	19.98	10.43	5.91	2.26	0.87	1.74	0.52	0.35	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	26.60	11.34	2.74	0.20	1.76	0.59	1.37	0.39	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	22.13	9.01	0.26	0.26	1.29	0.51	0.51	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	17.56	10.59	1.39	0.00	2.51	1.39	0.28	0.56	1.95
Adipocyte differentiation, day04, donor4	13028-139E4	19.40	8.82	1.18	0.59	2.94	1.76	0.00	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	18.74	11.34	1.85	0.16	1.85	1.93	0.32	0.48	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	19.04	11.30	2.90	0.00	1.61	0.65	1.29	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	14.93	9.60	2.67	0.00	1.60	1.07	1.07	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	14.47	8.35	1.67	0.56	0.56	2.23	0.56	0.56	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	11.23	6.65	3.33	0.00	2.50	2.91	0.42	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	18.34	10.55	1.26	0.75	1.26	2.01	1.51	0.50	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	13.09	7.85	0.65	0.00	0.98	2.62	0.65	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	15.53	9.13	1.83	0.00	1.52	1.22	0.91	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	13.26	7.73	1.55	0.00	0.44	1.10	0.44	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	8.96	5.74	0.36	0.36	0.72	0.00	1.43	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	3.59	2.40	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	25.19	21.59	1.98	0.36	1.62	1.26	0.18	0.36	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	23.43	10.04	0.00	0.00	3.35	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	25.48	22.80	3.70	0.82	0.82	1.23	0.41	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	11.44	8.12	2.52	0.11	0.92	0.11	0.34	0.11	0.00
Anulus Pulposus Cell, donor2	11463-119B5	10.29	5.14	1.96	0.24	0.24	0.24	0.00	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	8.09	3.15	0.45	0.00	0.45	1.35	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	7.38	4.34	0.87	0.00	0.87	0.00	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	0.00	4.28	0.00	0.00	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	7.17	3.29	0.60	0.30	0.30	0.90	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	2.53	1.26	0.00	0.00	0.00	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	6.60	0.66	1.32	0.00	0.00	0.00	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	6.50	6.17	0.32	0.00	0.00	0.32	0.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	8.74	5.83	1.46	0.00	0.97	0.97	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	5.94	2.97	0.59	0.00	0.59	0.00	0.59	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	9.42	4.52	0.00	0.00	0.38	0.00	1.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	9.43	7.26	0.73	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	7.52	1.25	1.25	0.00	0.00	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	8.40	3.13	1.32	0.00	0.33	0.82	0.16	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	12.28	8.19	0.00	0.00	0.00	1.36	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.73	1.96	0.30	0.00	0.15	0.30	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	9.64	4.82	1.07	0.00	0.00	0.54	0.54	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	10.58	4.16	0.94	0.00	0.38	0.38	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	10.16	5.61	1.07	0.00	0.00	0.27	0.80	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	9.75	8.78	0.00	0.00	0.00	0.98	1.95	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	7.96	4.98	1.00	0.00	0.50	0.50	0.17	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	3.60	1.20	1.20	0.00	0.00	0.00	2.40	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	3.54	0.00	0.00	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	7.38	3.43	0.51	0.00	0.00	0.00	0.17	0.00	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	4.19	0.00	0.00	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	7.28	1.46	0.97	0.00	0.00	0.49	1.46	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	6.45	6.45	1.14	0.00	0.76	0.00	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	10.90	2.42	3.63	0.00	0.00	0.00	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	7.98	3.42	0.00	0.00	0.00	0.00	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	8.34	3.42	0.86	0.00	1.07	0.21	0.64	0.00	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	10.58	3.36	1.29	0.00	0.26	0.52	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	8.45	3.28	0.47	0.00	0.00	0.00	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	10.93	1.93	0.64	0.00	0.32	0.32	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	4.99	2.14	1.43	0.00	0.00	0.00	1.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	8.77	3.51	0.58	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	8.13	3.31	1.20	0.30	0.60	0.00	0.90	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	4.75	2.38	1.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	9.66	2.54	0.51	0.00	0.00	0.51	1.02	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	10.70	3.31	0.76	0.00	0.00	0.51	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.90	3.18	0.64	0.00	1.91	0.00	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	6.90	6.04	1.29	0.00	0.86	0.00	0.86	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	8.04	4.23	0.64	0.00	0.64	0.00	0.21	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	5.51	2.03	0.87	0.00	0.58	0.00	0.00	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	4.72	3.78	2.83	0.00	0.94	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	7.46	3.56	0.51	0.00	0.34	1.02	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	2.32	0.00	2.32	0.00	0.00	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	2.11	2.11	0.00	2.11	2.11	4.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	9.01	3.65	1.07	0.00	0.86	0.00	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	8.42	4.21	1.20	0.00	0.00	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.75	1.46	0.73	0.00	1.46	0.00	2.92	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	7.59	3.22	0.00	0.00	0.23	0.69	1.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	2.55	0.00	0.00	0.00	2.55	2.55	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	4.07	1.78	1.27	0.25	0.76	0.25	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	8.88	4.54	0.83	0.00	0.41	0.00	0.41	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	5.51	2.75	1.53	0.00	0.00	0.31	0.92	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	9.08	1.91	0.48	0.00	0.00	0.00	0.48	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	7.98	2.88	1.11	0.00	0.67	0.22	0.44	0.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	0.00	0.00	0.00	0.00	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.31	1.11	0.00	0.00	0.55	0.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	9.80	3.97	1.06	0.00	0.53	0.00	0.00	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	4.36	3.27	0.73	0.00	0.36	0.36	0.00	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	15.11	3.93	5.04	0.00	0.61	0.25	0.25	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	10.78	3.77	3.25	0.00	0.17	0.34	0.68	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	22.86	7.34	6.92	0.00	0.21	0.21	1.05	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	16.03	6.62	6.62	0.00	0.35	0.00	0.35	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	19.41	8.41	6.31	0.00	0.00	0.00	1.94	0.16	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	21.78	9.99	6.26	0.00	0.60	0.15	1.49	0.15	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	66.29	13.76	4.24	0.00	0.69	0.57	2.41	0.23	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	74.67	15.79	4.01	0.00	1.00	0.88	2.00	0.25	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	66.68	11.49	4.10	0.11	0.91	0.57	1.93	0.00	0.00
Basophils, donor1	12241-129G9	88.40	51.52	0.52	0.26	0.78	3.40	1.31	3.92	1.83
Basophils, donor2	12242-129H1	102.83	83.34	0.36	0.36	1.44	6.13	1.44	10.82	1.08
Basophils, donor3	12243-129H2	96.72	63.94	3.97	0.00	2.06	5.14	1.03	4.56	2.79
Bronchial Epithelial Cell, donor1	11511-119G8	18.54	26.09	1.08	0.00	2.16	0.86	0.43	0.65	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	17.37	15.09	1.37	0.00	0.46	0.00	0.91	0.00	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	35.87	0.00	0.00	0.00	0.00	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	15.06	3.14	0.63	0.00	0.00	0.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	13.93	7.07	0.42	0.00	0.62	0.62	0.42	0.00	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	23.03	8.52	1.15	0.00	0.69	0.46	0.92	0.69	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	14.04	14.58	1.44	0.00	0.54	0.54	0.72	0.72	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	7.01	0.00	0.21	0.00	0.10	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	43.09	9.32	0.00	0.00	0.00	0.23	1.16	1.16	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	33.90	5.44	1.92	0.00	0.64	0.00	0.00	0.00	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	20.68	10.34	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	111.58	72.70	3.94	0.00	2.82	3.94	0.56	3.94	5.07
CD14+ Monocytes, donor2	11305-117B9	144.58	86.49	2.97	0.19	4.27	8.35	10.21	4.45	7.24
CD14+ Monocytes, donor3	11381-118B4	122.28	74.86	3.73	0.00	1.76	4.61	2.85	4.61	3.51
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	47.55	29.72	3.96	0.00	5.38	2.55	1.70	0.57	3.11
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	54.21	38.29	3.41	0.38	4.17	2.65	1.14	1.52	3.41
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	50.30	31.89	4.60	0.00	2.96	3.62	1.31	0.00	1.64
CD14+ monocytes - mock treated, donor1	11863-125A9	222.89	59.84	6.36	0.00	4.05	6.79	9.83	2.75	2.02
CD14+ monocytes - mock treated, donor2	11873-125C1	123.41	40.13	2.41	0.00	4.83	5.73	2.41	4.22	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	191.88	45.72	4.97	0.24	5.21	4.74	4.97	2.84	3.08
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	88.22	26.62	2.68	0.00	3.35	5.86	3.01	1.51	0.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	61.55	18.49	1.93	0.00	1.38	3.31	2.48	0.00	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	44.63	17.36	1.24	0.00	0.74	1.74	0.74	0.74	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	48.95	14.88	1.76	0.00	1.76	2.74	1.96	0.78	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	45.58	17.27	2.14	0.00	0.89	2.31	1.78	0.89	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	31.34	11.97	0.65	0.00	0.87	2.39	0.87	0.87	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	54.32	20.84	2.11	0.00	3.98	3.28	1.40	0.47	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	63.36	29.57	1.06	0.00	2.11	3.70	2.11	2.11	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	49.92	29.95	3.33	0.00	0.00	1.11	2.22	3.33	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	132.68	37.48	4.46	0.00	3.12	3.72	5.21	0.74	2.97
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	64.25	19.16	2.00	0.00	2.20	3.79	1.40	1.00	1.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	47.05	12.91	1.25	0.00	0.21	2.29	1.87	1.04	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	72.75	22.19	2.06	0.00	0.69	3.66	3.89	0.46	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	47.73	14.48	1.13	0.00	0.68	3.17	1.58	0.23	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	43.65	12.22	1.31	0.00	1.75	2.62	0.87	0.44	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	121.58	39.54	5.92	0.00	3.50	8.07	7.53	2.15	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	102.76	39.43	3.49	0.17	2.27	4.54	2.97	0.70	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	113.62	30.30	4.63	0.00	4.63	4.63	2.52	1.68	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	32.15	12.31	0.73	0.00	1.84	3.49	1.47	0.00	1.29
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	23.60	9.86	0.70	0.00	1.41	2.47	1.76	0.70	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	27.20	8.34	0.88	0.00	0.88	3.07	0.00	0.00	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	69.05	20.05	1.74	0.00	1.22	3.66	2.79	1.05	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	71.36	24.16	1.49	0.00	0.37	3.35	5.20	2.23	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	48.71	18.75	0.43	0.00	1.08	2.59	1.51	0.86	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	36.44	11.88	2.05	0.41	2.46	3.69	2.05	0.00	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	19.70	7.19	0.70	0.00	1.16	0.93	0.00	0.46	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	16.01	6.26	0.46	0.00	0.23	1.62	0.23	0.23	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	71.49	23.76	0.87	0.00	2.18	1.09	2.40	2.18	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	91.24	35.11	3.23	0.00	2.77	2.31	2.08	2.08	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	65.63	20.80	1.52	0.00	1.95	1.08	0.22	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	126.76	48.12	3.27	0.00	2.49	3.74	2.02	1.87	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	97.45	36.15	2.97	0.17	2.10	4.02	3.32	1.05	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	123.08	39.47	2.45	0.00	2.90	1.78	3.12	1.78	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	64.81	26.79	2.30	0.00	2.81	3.06	1.79	1.02	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	67.63	29.64	4.61	0.00	2.85	5.27	2.42	1.76	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	66.53	18.53	2.11	0.00	1.89	1.68	0.42	0.63	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	58.94	18.29	2.03	0.00	2.03	2.03	0.00	6.10	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	53.56	34.58	1.36	0.00	0.68	0.68	3.39	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	53.85	32.10	1.04	0.00	0.00	1.04	1.04	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	59.17	35.18	1.07	0.00	0.00	0.00	0.00	1.60	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	66.47	37.52	1.61	0.00	1.07	1.07	0.54	1.07	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	42.12	32.29	0.70	0.00	0.70	0.00	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	50.20	41.57	0.78	0.00	0.00	1.57	0.00	3.92	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	44.82	30.32	1.32	0.00	1.32	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	116.71	94.52	0.82	0.00	2.47	3.29	0.82	1.64	0.82
CD19+ B Cells, donor2	11624-122B4	155.97	103.01	0.73	0.00	0.00	2.18	2.18	7.25	0.00
CD19+ B Cells, donor3	11705-123B4	120.15	74.21	3.53	0.00	1.01	1.01	5.05	4.54	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	275.57	104.25	24.24	0.40	8.49	15.76	5.66	2.42	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	242.89	67.91	22.37	0.00	7.59	13.18	3.99	2.80	0.00
CD34+ Progenitors, donor1	11545-120B6	100.40	36.15	2.01	0.00	2.01	1.00	1.00	1.00	1.00
CD34+ Progenitors, donor2	11625-122B5	89.89	33.71	2.25	0.00	0.56	2.25	0.00	2.81	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	18.41	8.64	0.38	0.00	0.00	0.38	0.38	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	19.39	6.76	1.80	0.00	0.68	0.00	0.45	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	184.60	222.09	4.64	0.71	0.71	0.71	2.50	12.14	0.00
CD4+ T Cells, donor2	11306-117C1	189.22	218.00	3.67	0.61	1.22	2.45	18.98	17.15	0.61
CD4+ T Cells, donor3	11382-118B5	175.98	184.83	3.35	0.00	0.91	0.61	9.45	15.55	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	114.09	83.46	0.77	0.26	1.53	1.02	3.83	2.81	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	123.98	84.67	1.35	0.00	0.67	1.35	2.02	2.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	149.19	103.49	2.30	0.00	1.44	1.44	0.86	1.72	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	114.73	100.51	1.42	0.95	0.95	0.47	3.79	9.48	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	120.80	116.59	0.70	0.70	0.70	0.00	0.70	5.62	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	135.15	138.44	3.30	0.00	0.00	3.30	3.30	9.89	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	82.37	52.75	0.72	0.00	0.43	1.59	3.03	1.30	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	108.46	79.31	1.36	0.17	0.51	2.03	4.41	2.88	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	92.37	76.57	1.29	0.16	1.77	0.64	3.39	2.10	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	87.87	83.38	0.90	0.00	0.00	1.34	2.24	5.83	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	83.85	88.05	0.70	0.00	0.00	0.00	2.10	4.19	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	75.24	93.28	0.88	0.00	0.00	2.20	4.40	5.28	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	123.12	78.43	0.42	0.84	1.69	0.84	3.37	3.37	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	126.53	66.07	1.25	0.00	0.62	1.45	1.66	1.25	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	98.57	50.45	1.34	0.33	1.34	1.00	4.01	1.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	149.29	143.58	1.90	0.00	0.27	0.82	6.25	11.42	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	153.82	146.85	2.14	0.00	1.07	2.14	3.22	7.50	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	147.04	145.25	3.59	0.00	0.00	3.59	3.59	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	147.79	83.44	1.48	0.00	0.93	1.30	4.26	3.89	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	108.31	62.60	0.87	0.00	1.30	1.08	2.38	2.17	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	123.36	75.23	1.68	0.00	1.05	1.26	2.31	2.31	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	87.98	98.59	0.00	0.51	0.00	1.01	3.54	9.10	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	86.65	97.91	1.30	0.00	0.43	0.00	2.17	5.20	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	70.60	80.63	0.87	0.00	0.00	0.00	3.49	8.28	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	109.37	69.28	1.98	0.00	1.48	0.99	1.48	0.99	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	71.09	57.24	1.85	0.92	0.00	1.85	0.92	0.92	4.62
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	75.37	65.60	1.40	1.40	0.00	1.40	0.00	5.58	9.77
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	84.19	68.96	2.22	0.83	0.83	1.38	1.94	4.15	2.49
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	98.40	78.28	2.94	0.00	0.98	1.47	2.94	2.70	4.17
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	110.88	84.70	1.54	0.00	1.54	1.54	3.08	3.08	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	89.89	56.94	1.43	0.36	1.43	1.79	2.15	2.86	1.79
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	76.17	84.48	2.77	0.00	0.00	1.38	2.77	1.38	6.92
CD8+ T Cells, donor1	11226-116C2	207.90	206.59	2.29	0.00	1.31	2.95	2.95	18.33	2.29
CD8+ T Cells, donor2	11307-117C2	228.64	194.47	3.38	0.38	1.50	5.63	16.14	15.39	0.75
CD8+ T Cells, donor3	11383-118B6	223.96	190.12	3.79	0.25	3.03	2.27	7.83	14.90	3.03
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	36.70	11.70	0.23	0.00	0.46	1.38	1.15	0.92	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	34.51	13.66	0.72	0.00	0.48	0.96	0.72	0.72	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	30.64	10.67	0.27	0.00	2.19	0.55	1.64	1.37	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	35.42	17.11	0.00	0.00	0.90	0.60	1.80	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	47.04	21.12	0.24	0.00	2.16	1.44	1.92	2.88	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	42.29	17.28	1.14	0.00	1.36	1.59	1.14	1.36	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	44.76	20.86	0.43	0.00	0.87	1.30	1.30	0.43	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	48.17	18.42	0.53	0.00	1.84	1.84	1.84	1.05	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	45.97	14.07	0.47	0.00	1.17	1.41	3.52	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	43.47	21.13	0.60	0.00	1.81	1.51	3.02	1.51	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	44.16	11.04	0.58	0.00	2.32	1.74	1.16	1.16	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	46.36	14.92	0.27	0.00	0.27	1.33	2.40	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	60.85	28.89	0.44	0.00	1.31	2.63	0.88	2.19	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	71.96	25.96	0.46	0.00	0.46	2.28	0.91	2.73	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	76.82	27.60	0.75	0.00	0.00	1.49	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	50.42	24.13	0.72	0.00	1.44	1.80	2.52	1.08	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	45.46	24.46	1.15	0.00	1.15	2.59	0.58	1.15	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	41.72	24.98	0.47	0.00	1.89	3.30	1.41	2.12	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	44.37	23.45	0.63	0.00	0.95	2.22	3.17	1.58	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	45.83	23.07	0.62	0.00	0.92	2.15	0.92	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	48.73	26.29	0.00	0.00	0.96	1.60	1.28	1.92	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	34.04	21.42	0.38	0.00	0.76	0.76	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	39.02	20.10	0.39	0.00	1.58	0.79	2.76	0.79	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	34.04	12.86	0.00	0.00	0.00	0.00	3.03	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	65.04	12.85	1.61	0.00	0.80	0.00	0.00	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	69.24	16.09	0.00	0.00	2.10	0.70	2.10	0.00	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	76.13	23.04	1.00	0.00	0.00	0.00	2.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	56.66	10.97	1.83	5.48	1.83	5.48	0.00	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	16.30	3.95	0.99	0.49	0.49	0.49	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	14.73	7.16	0.95	0.11	0.42	0.74	0.42	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	5.20	6.93	4.85	0.00	1.04	1.73	0.00	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	6.04	4.26	1.78	0.36	0.00	0.71	0.00	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	9.90	6.14	1.82	0.11	0.68	0.68	0.34	0.00	0.23
Chondrocyte - re diff, donor2	11339-117F7	14.32	17.91	1.79	0.00	0.90	0.90	0.00	0.90	0.90
Chondrocyte - re diff, donor3	11411-118E7	9.71	6.07	3.64	0.00	1.21	0.40	0.81	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	7.34	3.56	4.02	0.00	0.11	0.23	0.46	0.11	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	8.55	2.14	2.78	0.00	0.21	0.21	0.64	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	11.24	3.54	3.27	0.00	0.35	0.27	0.00	0.09	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	33.75	29.80	12.10	2.66	3.03	2.93	1.38	1.28	1.56
Corneal Epithelial Cells, donor1	11526-119I5	29.20	24.15	1.76	0.00	1.54	2.20	0.00	0.44	0.22
Corneal Epithelial Cells, donor2	11606-120I4	20.48	29.58	1.14	0.00	0.00	0.00	2.28	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	24.03	17.89	1.79	0.00	0.51	1.28	2.05	0.51	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	24.76	24.27	1.65	0.00	3.14	2.64	0.99	0.66	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	24.29	20.50	1.89	0.00	2.21	6.62	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	3.45	0.00	0.00	0.00	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	20.41	21.38	1.08	0.00	2.92	2.81	1.19	0.86	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	171.50	81.65	1.02	0.00	1.02	1.71	1.71	6.49	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	110.34	57.45	0.00	0.00	0.65	1.31	0.00	3.92	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	105.50	67.27	0.48	0.00	0.00	0.97	0.97	4.36	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	13.01	3.84	0.33	0.00	0.00	0.50	0.00	0.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	9.39	2.93	0.00	0.00	0.59	0.59	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	22.91	7.35	0.57	0.00	0.57	1.13	0.57	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	14.15	5.11	1.97	0.00	0.39	0.00	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	14.83	5.24	2.04	0.00	0.87	0.58	0.58	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	15.76	7.29	0.24	0.00	0.71	1.18	1.65	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	11.92	4.91	1.23	0.00	0.53	0.53	0.35	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	14.19	5.76	1.11	0.00	0.66	0.44	0.22	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	17.34	4.87	1.52	0.00	1.22	0.91	0.91	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	14.38	6.77	1.41	0.00	0.85	0.28	0.85	0.56	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	10.99	7.73	0.59	0.00	1.49	0.59	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	9.89	5.21	0.00	0.00	0.52	1.04	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	16.59	5.96	1.70	0.00	0.71	0.71	0.43	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	13.60	6.80	0.00	0.00	1.20	0.80	1.20	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	11.53	6.29	0.52	0.00	1.05	0.52	2.62	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	16.52	5.34	0.87	0.00	0.25	0.37	0.62	0.12	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	9.78	4.13	1.30	0.00	0.22	0.22	0.65	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	17.71	4.03	1.59	0.00	0.61	0.00	0.37	0.24	0.00
Endothelial Cells - Vein, donor1	11267-116G7	10.24	3.41	0.00	0.00	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	13.97	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	16.96	6.91	1.10	0.00	0.31	0.31	0.31	0.47	0.00
Eosinophils, donor1	12244-129H3	91.48	30.49	0.00	0.00	0.00	0.00	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	181.53	103.97	9.90	0.00	8.25	6.60	1.65	4.95	3.30
Eosinophils, donor3	12246-129H5	131.97	78.47	10.70	0.00	3.57	10.70	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	20.52	22.72	0.73	0.00	0.98	0.49	1.22	0.24	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	27.04	10.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	48.81	0.00	0.00	0.00	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	9.03	9.03	1.64	0.00	0.82	0.82	0.00	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	2.30	2.74	0.99	0.11	0.22	0.99	1.64	0.11	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	12.24	4.88	1.41	0.00	1.19	0.11	2.28	0.11	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	9.58	5.58	1.09	0.00	0.61	0.49	0.12	0.12	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	3.28	4.23	0.96	0.00	0.96	0.68	0.14	0.27	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	14.34	8.44	2.00	0.00	0.74	0.21	1.69	0.11	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	14.23	12.65	1.58	0.00	0.79	0.53	0.26	0.00	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	18.27	9.63	1.33	0.00	1.66	0.33	1.00	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	12.70	2.72	2.27	0.00	0.00	0.00	0.91	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	10.61	2.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	14.19	5.05	0.95	0.00	0.32	0.63	0.79	0.47	0.00
Fibroblast - Cardiac, donor4	11452-119A3	25.16	12.43	2.42	0.30	0.61	0.91	1.21	0.00	1.21
Fibroblast - Cardiac, donor5	11456-119A7	22.34	8.25	1.02	0.13	0.38	0.51	1.02	0.25	0.89
Fibroblast - Cardiac, donor6	11460-119B2	13.49	4.85	1.52	0.45	0.91	0.30	0.30	0.30	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	18.89	5.63	2.01	0.13	0.94	0.40	0.13	0.40	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	25.89	4.75	2.59	0.00	0.00	0.86	0.43	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	5.86	2.93	0.00	0.00	1.46	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	38.06	10.61	1.38	0.46	0.23	0.69	0.23	0.00	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	26.63	21.03	3.05	0.85	2.20	1.53	1.53	0.51	0.17
Fibroblast - Dermal, donor1	11269-116G9	16.67	4.93	1.64	0.23	0.23	0.00	0.47	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	7.55	7.55	0.00	0.00	0.47	0.94	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	19.10	8.46	1.09	0.12	0.97	1.09	0.48	0.12	0.12
Fibroblast - Dermal, donor4	11450-119A1	13.45	4.75	0.68	0.34	0.45	0.23	1.02	0.11	0.34
Fibroblast - Dermal, donor5	11454-119A5	20.24	6.45	0.70	0.00	0.52	0.17	0.35	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	18.52	5.85	0.81	0.81	0.65	0.16	1.14	0.00	0.00
Fibroblast - Gingival, donor1	11237-116D4	15.20	10.00	1.04	0.21	1.04	0.83	0.00	0.21	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	16.77	8.91	2.36	0.00	1.83	0.26	0.79	0.00	0.52
Fibroblast - Gingival, donor2	11318-117D4	18.71	6.06	2.24	0.00	0.66	0.26	0.66	0.13	0.26
Fibroblast - Gingival, donor3	11394-118C8	35.19	19.43	2.61	0.58	1.16	0.77	1.16	0.29	0.87
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	16.62	12.47	3.12	0.00	5.19	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	17.62	8.63	2.82	0.00	0.53	0.35	0.53	0.00	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	13.72	5.77	1.71	0.00	0.31	0.31	0.31	0.16	1.25
Fibroblast - Gingival, donor6 (control)	11922-125H5	8.93	4.19	2.03	0.00	0.95	0.27	0.41	0.27	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	24.00	7.76	3.88	0.00	2.47	1.06	0.00	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	8.63	3.51	2.78	0.00	0.73	0.00	0.00	0.00	0.88
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	12.68	7.23	2.45	0.00	1.36	0.55	0.55	0.27	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	18.10	6.58	1.43	0.00	0.99	0.88	0.66	0.00	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	18.34	12.03	3.96	0.00	1.61	0.73	1.03	0.29	0.00
Fibroblast - Lung, donor1	11270-116H1	4.08	1.36	0.00	0.00	2.72	1.36	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	22.38	13.43	1.49	0.00	0.00	0.00	0.00	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	24.90	10.55	0.84	0.21	1.27	0.21	0.84	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	44.15	18.33	3.33	0.83	0.83	1.67	0.83	0.00	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	9.79	6.99	2.80	0.00	1.40	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	16.51	7.84	1.12	0.84	0.84	0.00	0.84	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	45.06	21.92	1.62	0.41	2.03	1.22	0.41	0.41	0.41
Fibroblast - Mammary, donor2	11620-122A9	23.97	7.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	11.91	0.00	0.00	0.00	0.00	0.00	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	12.22	6.01	0.58	0.00	0.39	0.00	0.19	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	19.72	6.83	1.21	0.15	0.15	0.30	1.52	0.00	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	20.20	9.79	0.31	0.00	1.84	2.14	0.00	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	14.88	4.58	1.14	0.00	1.91	0.38	0.00	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	12.69	5.94	0.54	0.00	0.54	0.27	1.08	0.00	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	22.61	9.97	4.52	0.12	1.39	1.16	1.28	0.35	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	10.06	3.98	0.22	0.22	0.66	0.33	0.22	0.00	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	23.98	10.97	2.84	0.00	1.83	0.81	0.00	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	30.07	6.68	2.67	0.67	1.34	0.00	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	17.79	6.72	1.19	0.40	0.79	1.19	0.40	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	12.70	5.56	1.79	0.00	1.19	0.79	0.60	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	9.59	3.02	1.24	0.00	1.07	1.07	0.71	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	9.66	7.10	0.79	0.20	0.79	0.59	0.00	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	11.13	4.81	2.11	0.00	1.50	0.90	0.00	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	11.87	5.51	1.19	0.11	0.65	0.54	0.32	0.00	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	10.88	10.63	2.02	0.00	1.52	0.51	0.25	0.51	0.76
Fibroblast - skin normal, donor1	11553-120C5	11.65	5.58	2.95	0.00	0.82	0.98	0.33	0.33	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	10.43	8.82	0.40	0.00	1.20	0.60	0.00	0.00	0.20
Fibroblast - skin normal, donor2	11561-120D4	12.06	6.13	1.00	0.00	0.70	0.20	1.31	0.10	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	7.56	4.53	2.12	0.00	1.51	0.00	0.60	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	9.78	5.47	0.75	0.17	1.33	0.25	0.33	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	12.31	14.53	2.56	0.00	1.88	0.51	1.37	0.34	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	6.57	3.61	2.63	0.00	0.99	0.33	0.00	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	6.07	3.83	2.13	0.00	0.00	0.53	0.43	0.00	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	10.29	5.06	1.01	0.00	0.67	0.67	0.17	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	6.27	2.04	0.63	0.31	0.31	0.16	1.41	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	34.86	34.86	5.23	0.87	1.74	1.74	0.87	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	23.92	15.08	0.87	0.00	1.73	2.08	0.00	0.17	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	19.26	9.63	0.52	0.00	0.52	1.56	1.04	0.52	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	18.14	11.50	0.51	0.26	1.28	1.53	0.77	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	12.25	1.53	1.53	0.00	0.00	0.00	1.53	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	10.85	1.28	2.55	0.64	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	18.83	0.57	0.57	0.00	0.00	0.00	0.29	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	19.58	4.96	2.21	0.00	0.28	0.00	0.55	0.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	21.92	6.62	5.48	0.00	1.14	0.23	0.46	0.00	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	20.21	1.59	1.59	0.00	0.00	0.00	0.59	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	20.35	4.76	2.38	0.00	0.00	0.00	0.00	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	17.61	4.57	4.57	0.00	0.00	0.00	0.33	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	11.06	0.00	2.21	0.44	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	21.62	4.80	1.55	0.00	0.14	0.00	1.27	0.14	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	20.44	5.79	2.22	0.00	0.00	0.12	1.35	0.25	1.35
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	20.42	4.03	1.07	0.00	0.00	0.54	1.07	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	24.04	9.17	1.98	0.00	0.25	0.12	0.87	0.37	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	26.85	7.06	0.97	0.00	0.28	0.00	0.69	0.28	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	21.96	3.46	1.42	0.20	0.20	0.00	1.42	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	21.91	11.64	1.83	0.00	0.23	0.23	0.91	0.68	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	24.04	8.84	1.74	0.12	0.00	0.00	1.12	0.00	1.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	22.29	8.96	1.09	0.00	0.22	0.22	0.44	0.00	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	22.16	10.34	2.66	0.00	0.00	0.00	1.48	0.00	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	25.75	8.11	2.70	0.00	0.32	0.16	2.23	0.00	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	22.79	5.36	2.90	0.00	0.22	0.00	0.45	0.00	1.56
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	33.87	13.11	3.83	0.00	0.40	0.20	1.61	0.60	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	33.76	9.33	2.21	0.00	0.17	0.17	1.53	0.17	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	28.91	10.91	2.31	0.00	0.35	0.44	0.53	0.35	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	44.22	19.15	5.41	0.00	0.83	0.10	0.10	0.52	0.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	40.64	17.59	6.32	0.00	1.02	0.68	0.17	0.00	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	28.66	14.05	4.54	0.11	0.77	0.33	1.22	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	24.13	10.15	2.58	0.17	0.42	0.17	0.67	0.50	0.92
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	25.52	10.41	2.86	0.00	0.20	0.00	0.41	0.41	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	26.20	16.71	3.51	0.00	0.62	0.00	1.44	0.00	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	36.20	15.22	3.69	0.00	0.12	0.23	1.27	0.58	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	25.52	9.67	3.50	0.17	0.17	0.17	0.67	0.00	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	36.81	18.30	4.41	0.00	0.00	0.88	1.32	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	32.84	19.56	4.55	0.00	0.49	0.37	1.72	0.37	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	22.69	7.62	3.57	0.00	0.65	0.00	0.32	0.16	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	27.26	14.11	4.49	0.32	0.00	0.96	1.60	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	32.03	16.96	3.79	0.00	0.57	0.38	1.61	0.19	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	27.52	11.71	2.53	0.00	0.32	0.47	0.63	0.79	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	34.06	13.38	3.65	0.00	0.00	0.00	1.82	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	28.12	16.10	3.97	0.00	0.73	0.84	1.36	0.63	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	20.64	16.47	3.29	0.00	0.00	0.22	0.44	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	33.10	14.87	4.21	0.28	1.40	0.56	1.12	0.84	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	37.41	14.91	3.80	0.00	0.83	0.37	1.30	0.09	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	26.21	11.23	2.94	0.00	0.27	0.53	1.87	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	34.27	12.85	3.21	0.00	0.77	0.31	1.68	0.46	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	30.57	11.40	2.20	0.00	0.52	0.65	2.07	0.00	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	29.55	13.82	4.34	0.00	0.00	0.81	0.54	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	35.03	20.28	4.24	0.00	0.18	0.55	1.47	0.55	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	39.04	21.27	5.92	0.00	0.22	0.66	1.54	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	45.62	24.79	15.87	0.00	1.98	0.00	2.98	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	37.59	16.62	3.69	0.00	0.79	0.66	1.19	0.53	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	36.32	15.74	3.23	0.00	0.40	0.40	1.61	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	51.34	43.97	13.22	0.51	2.03	2.29	0.76	1.27	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	17.12	1.79	2.39	0.00	0.20	0.00	0.20	0.00	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	23.27	4.47	1.69	0.00	0.00	0.00	1.08	0.31	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	30.89	3.48	1.64	0.00	0.20	0.00	0.20	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	12.52	1.88	1.88	0.00	0.00	0.00	0.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	6.50	1.98	0.28	0.00	0.28	0.28	1.13	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	21.68	0.46	2.31	0.46	0.00	0.46	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	22.27	2.47	2.47	0.00	0.00	0.00	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	10.44	2.32	1.16	0.00	0.39	0.00	0.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	12.84	0.00	1.60	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	10.43	3.48	1.74	0.00	0.00	0.00	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	9.11	1.95	0.98	0.00	0.00	0.00	0.00	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	16.47	2.06	0.41	0.00	0.41	0.00	1.24	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	3.33	0.00	3.33	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	13.98	2.24	0.28	0.56	0.56	0.00	0.28	0.00	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	12.42	2.29	1.31	0.00	0.00	0.00	0.33	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	17.62	2.52	0.84	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	24.81	3.50	2.23	0.00	0.00	0.00	0.64	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	15.28	1.70	2.04	0.00	0.34	0.34	0.34	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	14.62	2.09	0.00	0.00	0.00	0.00	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	20.04	3.44	1.72	0.57	0.00	0.00	0.00	0.00	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	14.21	2.96	0.30	0.00	0.30	0.00	0.59	0.00	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	8.47	0.00	3.39	0.00	0.00	0.00	1.69	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	17.40	3.31	0.41	0.00	0.00	0.00	0.41	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	14.27	2.99	1.15	0.00	0.23	0.23	0.69	0.00	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	5.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	16.15	4.23	2.31	0.00	0.00	0.38	0.77	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	14.02	4.89	1.30	0.00	0.00	0.00	0.65	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	16.05	2.01	1.34	0.00	0.00	0.00	0.67	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	15.03	5.78	2.31	0.39	0.00	0.39	1.93	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	21.23	5.82	1.37	0.00	0.00	0.34	0.34	0.68	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	9.94	9.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	19.35	4.72	1.42	0.47	0.47	0.00	0.47	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	18.10	3.62	2.41	0.00	0.00	0.00	0.60	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	15.77	3.05	4.58	0.00	1.02	0.51	0.51	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	16.75	4.39	0.40	0.00	0.00	0.00	0.80	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	12.83	3.95	1.97	0.00	0.00	0.00	0.00	0.00	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	15.35	1.18	0.00	0.00	0.00	0.00	1.18	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	12.25	2.92	1.75	0.00	0.00	0.00	0.00	0.00	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	18.43	5.71	2.63	0.44	0.00	0.00	0.00	0.00	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	16.95	5.09	0.85	0.00	0.85	0.00	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	8.95	5.97	0.00	0.60	0.60	0.00	0.60	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	8.25	3.88	1.94	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	15.98	3.42	1.14	0.00	0.00	1.14	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	28.69	7.48	4.57	0.00	0.83	1.25	0.83	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	14.62	6.75	0.00	0.00	1.12	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	25.69	11.73	6.66	1.59	1.59	2.54	1.27	0.00	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	8.35	7.94	3.34	0.84	1.67	0.00	0.00	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	21.93	14.39	1.39	0.00	1.51	1.39	1.16	0.58	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	28.70	18.40	2.36	0.00	1.18	1.52	2.03	0.84	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	22.07	15.93	2.96	0.00	1.14	2.73	1.82	0.68	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	21.75	15.30	1.42	0.00	1.20	1.86	0.87	0.55	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	21.71	14.18	0.86	0.00	1.72	1.07	1.50	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	17.65	12.70	0.65	0.00	1.94	0.86	0.43	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	13.70	9.84	0.00	0.00	1.49	1.12	0.50	0.62	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	14.92	8.06	0.86	0.00	1.03	1.72	1.20	0.34	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	10.25	7.69	0.64	0.00	1.28	0.64	0.64	0.64	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	29.66	6.72	0.56	0.00	0.00	0.00	1.68	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	16.45	10.82	1.73	0.00	0.43	0.43	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	5.29	0.00	0.00	0.00	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	21.16	11.99	2.47	1.06	1.76	0.71	1.06	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	25.43	12.35	3.63	1.45	1.45	0.73	0.00	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	11.54	4.90	0.70	0.35	0.87	0.52	0.17	0.00	0.00
Hepatocyte, donor1	11523-119I2	24.21	10.90	1.21	7.26	0.00	2.42	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	48.48	9.70	0.00	0.00	2.15	2.15	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	22.70	9.82	0.61	1.84	2.45	0.61	0.00	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	55.48	10.44	2.61	0.00	0.00	0.65	1.31	0.65	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	53.13	16.25	1.22	0.00	0.70	1.05	1.05	0.87	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	6.04	2.47	1.37	0.00	0.55	0.27	0.27	0.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	3.18	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	1.38	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	4.87	0.00	1.62	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	3.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	3.63	3.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	7.94	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	4.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	5.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	5.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	7.73	1.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	5.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	0.00	1.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	3.26	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2.94	0.84	0.00	0.00	0.42	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	8.84	0.80	0.80	0.00	0.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	3.69	0.92	0.00	0.00	0.00	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	3.30	0.94	0.47	0.00	0.47	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.91	0.00	1.81	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	4.30	1.08	1.08	0.00	0.00	0.00	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	5.08	0.00	1.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	3.83	1.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	1.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	4.28	0.00	0.71	0.00	0.71	0.00	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	4.63	1.54	0.00	0.00	0.00	0.00	0.93	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	8.78	1.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	4.17	0.70	0.70	0.00	0.00	0.70	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2.21	0.00	2.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	7.85	0.87	0.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	2.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	5.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	5.52	0.00	0.00	0.00	0.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	6.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1.06	0.00	0.00	0.00	0.00	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	33.62	24.56	1.39	0.00	2.45	1.55	0.49	1.63	0.08
Keratinocyte - epidermal, donor2	11349-117G8	8.20	6.44	0.00	0.00	1.17	1.17	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	29.53	24.23	0.66	0.00	0.95	0.76	0.95	0.47	0.00
Keratinocyte - oral, donor1	11251-116E9	27.70	27.81	1.14	0.00	1.02	1.14	0.34	0.79	0.23
Keratocytes, donor1	11527-119I6	48.82	19.60	0.69	0.00	1.38	0.69	0.69	0.69	0.34
Keratocytes, donor2	11607-120I5	17.58	9.37	0.00	1.17	0.00	1.17	1.17	0.00	1.17
Keratocytes, donor3	11688-122I5	47.82	22.72	3.16	0.59	1.58	1.19	0.99	0.79	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	24.18	6.59	4.40	0.00	0.00	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	8.63	4.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	15.34	7.04	4.50	0.00	0.23	0.58	0.58	0.12	0.00
Lens Epithelial Cells, donor3	11690-122I7	6.86	4.74	1.01	0.00	0.50	0.50	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	6.88	2.61	0.83	0.00	0.12	0.24	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	5.02	1.40	0.00	0.00	0.00	0.00	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	7.56	1.57	0.79	0.00	0.31	0.16	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	6.45	4.30	0.00	0.00	0.54	0.54	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	8.51	1.89	0.00	0.00	0.00	0.32	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	5.61	2.48	0.32	0.00	0.54	0.11	0.22	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	9.03	2.46	0.00	0.00	0.41	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	6.32	1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	8.45	2.67	0.56	0.00	0.14	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	9.49	5.14	0.00	0.00	0.00	0.40	0.40	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	8.53	2.91	0.39	0.00	0.00	0.39	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.78	3.15	0.37	0.00	0.19	0.37	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	10.10	2.09	0.35	0.00	0.00	0.00	0.00	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	10.26	1.67	0.95	0.00	0.24	0.00	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.73	1.79	0.96	0.00	0.96	0.14	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	10.78	2.77	0.62	0.00	0.62	0.31	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	2.81	1.25	0.62	0.00	0.00	0.00	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	9.33	3.66	0.73	0.00	0.73	0.55	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	5.92	3.29	0.00	0.00	0.00	0.00	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.61	2.64	0.88	0.00	0.59	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	7.72	3.24	1.00	0.00	0.50	0.25	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	6.79	1.45	1.45	0.00	0.00	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	12.12	4.85	0.27	0.00	0.00	0.00	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	11.35	3.94	0.61	0.00	0.45	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	7.26	4.15	0.52	0.00	0.00	0.00	0.52	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	10.47	4.61	0.42	0.00	0.42	0.00	0.21	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	9.77	3.91	0.45	0.00	0.45	0.15	0.60	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	13.76	2.75	0.69	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	10.16	3.57	0.56	0.00	0.38	0.19	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.22	3.39	0.53	0.00	0.21	0.11	0.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	9.69	4.36	0.00	0.00	0.48	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	14.22	5.62	0.33	0.00	0.33	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	7.56	2.60	0.74	0.00	0.87	0.25	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	8.14	1.85	0.37	0.00	0.37	0.74	0.37	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	7.91	2.72	0.99	0.00	0.74	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.70	3.16	0.96	0.00	0.14	0.00	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	7.40	2.89	0.96	0.00	0.64	0.00	0.64	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	13.09	4.56	0.61	0.00	0.00	0.30	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	11.62	3.36	0.56	0.00	0.28	0.00	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	4.98	3.56	0.71	0.00	1.07	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	12.12	5.33	0.00	0.00	0.48	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.78	2.02	0.93	0.00	0.31	0.31	0.47	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	5.01	2.51	0.36	0.00	0.36	0.36	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	16.01	7.51	0.65	0.00	0.65	0.00	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.36	2.83	0.47	0.00	0.71	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	10.27	3.22	0.74	0.00	0.37	0.62	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	13.32	4.87	1.79	0.00	0.51	0.00	0.00	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.97	2.69	0.90	0.00	0.30	0.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2.27	0.00	6.80	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	8.44	0.77	3.07	0.00	0.00	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	4.45	0.74	0.74	0.00	0.00	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	5.50	2.54	2.54	0.00	0.00	0.00	0.85	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	4.92	1.41	2.81	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	5.60	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	5.15	1.55	3.61	0.00	0.52	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	7.14	0.00	3.57	0.00	0.00	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	5.43	1.13	2.26	0.00	0.00	0.00	0.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	5.23	1.45	2.33	0.00	0.00	0.29	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	7.65	1.35	1.80	0.00	0.00	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	8.67	2.98	2.03	0.00	0.00	0.14	0.14	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	7.19	0.00	1.03	0.00	0.51	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	4.59	0.71	2.82	0.00	0.00	0.00	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	5.33	2.67	0.67	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	8.15	1.53	3.06	0.00	0.00	0.51	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	8.27	0.27	2.40	0.00	0.00	0.27	0.53	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	6.24	3.21	2.65	0.00	0.00	0.00	0.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	7.36	1.84	2.45	0.00	0.00	0.00	1.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	12.23	2.45	3.26	0.00	0.00	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	7.71	2.50	3.54	0.00	0.00	0.21	0.21	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	6.73	2.80	1.96	0.00	0.28	0.00	1.12	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	11.33	2.06	5.15	0.00	0.00	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	5.81	2.03	2.32	0.00	0.00	0.29	0.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	4.48	2.99	2.09	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	8.30	0.55	3.87	0.00	0.00	0.00	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	9.54	2.47	1.41	0.00	0.00	0.00	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	7.74	1.11	2.95	0.00	0.74	0.00	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	8.06	0.00	2.30	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	9.98	3.45	2.30	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	9.06	5.10	3.40	0.00	0.00	0.00	0.57	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	10.67	0.00	0.82	0.00	0.82	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	6.78	4.07	2.71	0.00	0.00	0.00	0.45	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	7.90	2.87	2.15	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	5.23	2.99	2.99	0.00	0.00	0.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	6.69	4.46	2.60	0.00	0.00	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	7.75	3.45	1.72	0.00	0.00	0.00	0.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	7.71	4.28	5.14	0.00	0.00	0.00	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	10.33	3.00	3.66	0.00	0.00	0.33	0.67	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	6.03	0.60	3.02	0.00	0.00	0.00	1.21	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	8.53	0.71	0.71	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	8.59	1.03	1.72	0.00	0.34	0.00	1.03	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	10.20	2.15	1.61	0.00	0.00	0.00	1.07	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	6.06	2.02	4.04	0.00	0.00	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	13.71	4.44	2.22	0.00	0.00	0.00	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	2.33	0.00	2.33	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	8.46	4.23	2.12	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	7.20	2.40	4.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	4.36	2.18	4.36	0.00	0.00	0.00	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	7.67	0.77	4.60	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	6.91	0.99	1.97	0.00	0.00	0.00	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	8.47	0.94	1.88	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	6.54	2.01	3.02	0.00	0.00	0.00	1.01	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	10.36	3.15	1.80	0.00	0.00	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	8.61	3.44	1.72	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	10.69	0.45	2.67	0.00	0.00	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	14.47	3.52	3.52	0.00	0.39	0.39	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	11.22	3.96	1.32	0.00	0.00	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	9.86	3.11	2.08	0.00	0.00	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	12.69	1.31	2.19	0.00	0.44	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	11.18	0.56	2.80	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	13.69	2.21	3.53	0.00	0.44	0.00	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	5.40	4.63	3.09	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	13.17	2.03	2.03	0.51	0.00	0.00	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	12.50	3.36	1.92	0.00	0.00	0.00	0.48	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	13.91	3.98	3.98	0.00	0.40	0.00	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	12.15	1.82	1.82	0.00	0.61	0.00	0.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	15.22	2.08	0.69	0.00	0.00	0.00	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	11.02	4.18	4.18	0.00	0.00	0.38	0.38	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	10.33	3.10	1.03	0.00	0.00	0.00	1.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	13.30	4.84	1.81	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	14.58	4.75	2.85	0.00	0.32	0.32	0.63	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	15.99	8.53	2.13	0.00	1.07	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	16.67	4.02	0.57	0.00	0.57	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	12.34	4.11	3.60	0.00	0.51	0.00	1.54	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	13.44	5.66	0.71	0.00	0.00	0.00	0.00	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	13.62	5.11	3.97	0.00	0.00	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	13.73	3.74	4.16	0.00	0.00	0.00	2.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	10.96	8.61	3.92	0.00	0.00	0.78	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	11.27	3.34	3.34	0.00	0.00	0.84	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	14.40	4.18	2.32	0.00	0.46	0.46	0.46	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	10.04	3.35	4.01	0.00	0.00	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	11.76	2.67	3.21	0.00	0.00	0.00	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	13.74	6.47	2.83	0.00	0.00	0.40	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	9.18	4.59	0.92	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	14.23	6.22	3.56	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	17.67	5.70	2.85	0.00	1.14	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	9.20	3.07	2.30	0.00	0.00	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	7.66	2.19	1.64	0.00	0.00	0.00	0.55	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	8.46	3.12	2.23	0.00	0.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	12.74	3.90	2.60	0.00	0.52	0.00	0.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	11.27	5.97	3.32	0.00	0.00	0.00	1.33	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	10.39	0.00	6.24	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	27.58	20.28	0.91	0.00	3.42	1.82	0.91	0.68	0.00
Macrophage - monocyte derived, donor2	11313-117C8	8.44	11.01	1.28	0.00	2.57	2.39	0.73	0.37	0.18
Macrophage - monocyte derived, donor3	11389-118C3	28.18	19.01	2.36	0.00	4.72	2.23	0.79	0.79	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	8.50	7.97	0.00	0.00	1.59	1.06	0.00	0.00	1.06
Mallassez-derived cells, donor2	11929-125I3	21.07	14.58	1.27	0.00	1.27	1.58	1.27	0.79	0.16
Mallassez-derived cells, donor3	11930-125I4	20.29	7.78	0.14	0.00	0.83	1.39	0.97	0.83	0.14
Mammary Epithelial Cell, donor1	11273-116H4	22.72	17.64	0.40	0.00	2.29	1.30	0.50	0.40	0.10
Mammary Epithelial Cell, donor2	11350-117G9	27.80	22.87	1.16	0.00	1.45	0.87	0.29	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	22.70	11.97	0.50	0.25	1.00	0.50	0.25	0.50	0.50
Mast cell - stimulated, donor1	11487-119E2	17.63	24.41	0.00	0.00	2.71	2.03	2.03	1.36	0.00
Mast cell, donor1	11563-120D6	82.62	37.85	2.81	0.43	3.14	1.08	1.95	0.65	0.32
Mast cell, donor2	11565-120D8	79.64	34.47	4.46	0.59	3.57	2.38	3.57	1.19	1.78
Mast cell, donor3	11566-120D9	119.32	53.58	5.85	0.68	6.98	4.50	2.03	1.13	7.20
Mast cell, donor4	11567-120E1	112.22	54.61	6.91	0.35	9.57	2.48	3.90	0.89	2.48
Mast cell, expanded and stimulated, donor5	11940-126A5	50.35	17.08	2.44	0.00	2.00	0.78	1.66	0.67	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	87.55	32.69	1.75	0.58	2.33	0.58	1.75	5.25	0.00
Mast cell, expanded, donor5	11939-126A4	47.15	13.77	3.44	0.11	1.38	1.38	1.84	0.11	0.46
Mast cell, expanded, donor8	11941-126A6	102.43	13.56	3.35	0.17	2.34	1.00	2.51	0.84	1.17
Melanocyte - dark, donor1	11502-119F8	14.63	5.57	0.50	0.00	0.99	0.40	0.00	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	9.69	5.19	0.69	0.35	0.35	0.69	0.35	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	21.08	13.76	2.83	0.00	1.01	0.43	0.36	0.87	0.07
Melanocyte - light, donor1	11274-116H5	27.27	12.22	4.23	0.00	1.18	0.47	0.24	0.47	0.00
Melanocyte - light, donor2	11351-117H1	17.06	10.24	5.46	0.00	0.00	0.68	0.00	0.68	0.68
Melanocyte - light, donor3	11423-118G1	12.14	2.60	0.87	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	20.20	7.39	3.64	0.00	0.52	0.73	0.83	0.10	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	24.20	13.72	2.42	0.00	0.81	0.54	0.00	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	20.89	8.04	3.75	0.00	0.27	0.27	0.00	0.54	0.00
Meningeal Cells, donor1	11493-119E8	30.64	8.56	2.23	0.00	0.50	0.12	0.25	0.12	0.00
Meningeal Cells, donor2	11573-120E7	14.52	3.52	4.40	0.00	0.88	0.00	0.88	0.00	0.44
Meningeal Cells, donor3	11654-122E7	19.72	4.40	0.98	0.00	0.16	0.08	0.33	0.08	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	7.41	3.14	1.43	0.00	0.00	0.29	0.00	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	7.14	4.53	1.51	0.00	0.70	0.60	0.10	0.30	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	21.03	22.34	0.00	2.63	1.31	1.31	0.00	1.31	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	30.09	5.23	0.00	0.00	0.00	1.31	0.00	0.00	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	25.83	7.18	0.00	0.00	0.72	0.00	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	8.26	2.12	1.48	0.00	0.42	0.21	0.21	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	2.01	2.01	2.01	0.00	0.00	0.00	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	14.72	4.18	1.32	0.00	0.00	0.44	0.66	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	6.58	2.92	0.00	0.00	0.00	0.00	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	7.37	2.25	1.02	0.20	0.20	0.20	0.41	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	9.00	6.79	2.63	0.42	0.69	0.55	0.14	0.14	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	30.48	9.66	5.58	0.37	0.74	0.74	1.12	0.00	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	18.55	9.74	1.32	0.53	1.18	0.92	0.39	0.13	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	27.89	10.98	2.37	1.78	0.59	1.48	1.19	0.30	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	14.01	7.01	0.00	0.00	0.00	0.00	4.67	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	20.49	7.04	0.64	1.92	0.64	0.00	0.64	0.00	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	20.20	4.96	0.35	0.00	1.42	0.35	0.71	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	12.20	12.51	0.00	0.31	1.25	0.63	0.00	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	9.43	3.63	0.73	0.00	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	5.04	1.06	1.59	0.00	0.53	0.27	0.27	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	1.00	2.50	0.50	0.00	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	5.64	4.19	1.66	0.00	0.29	0.22	0.22	0.07	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	18.90	13.50	2.70	0.00	2.70	4.05	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	23.89	16.75	1.23	0.00	2.71	1.97	0.74	0.74	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	11.19	15.02	1.77	0.00	0.59	1.18	0.29	0.88	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	10.37	3.46	0.00	3.46	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	13.95	10.23	1.24	0.00	0.62	1.55	0.31	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	13.48	10.99	1.04	0.00	1.24	1.24	0.21	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	13.90	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	21.02	15.27	2.75	0.00	2.75	3.25	1.25	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	16.76	18.62	1.86	0.00	3.26	0.47	0.93	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	17.88	12.80	1.02	0.00	2.24	2.44	1.22	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	15.84	9.90	2.77	0.00	2.77	2.38	1.19	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	17.10	8.55	0.00	0.00	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	16.81	6.19	0.00	0.00	1.77	4.42	1.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	11.02	9.88	3.42	0.00	1.90	1.52	0.76	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	5.26	1.32	0.00	0.00	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	12.95	8.70	0.85	0.00	1.27	1.91	0.85	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	7.37	7.37	0.92	0.00	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	9.84	7.75	0.89	0.00	0.30	0.89	0.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	5.03	1.68	0.00	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	12.80	8.03	0.50	0.00	1.76	2.01	1.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	10.22	10.93	1.19	0.00	1.19	1.19	0.24	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	7.19	7.74	0.00	0.00	1.66	1.66	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	13.58	7.14	1.38	0.00	1.38	1.84	0.23	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	11.99	8.62	1.68	0.00	1.47	2.52	0.21	0.42	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	12.03	9.99	1.63	0.00	1.63	1.63	0.41	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	12.44	7.08	0.86	0.00	1.50	0.86	0.64	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	13.12	10.23	1.78	0.00	2.89	1.11	0.22	0.67	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	12.70	8.98	0.22	0.00	1.53	2.85	0.22	0.66	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	8.62	8.62	0.00	0.00	1.52	1.52	0.00	1.01	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	16.57	9.94	1.66	0.00	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	18.48	11.42	1.63	0.00	2.99	1.36	1.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	13.82	11.18	1.47	0.00	2.06	2.65	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	11.99	0.00	0.00	1.09	2.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	13.46	10.57	0.00	0.00	0.96	0.96	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	21.21	15.61	1.60	0.00	1.60	2.00	1.60	1.60	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	16.45	12.34	0.00	0.00	4.11	5.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	12.51	9.51	0.50	0.00	1.00	2.50	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	26.95	0.00	0.00	0.00	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	8.15	0.00	0.00	2.04	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	8.32	7.88	0.44	0.00	0.88	1.31	0.44	1.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	14.35	7.73	0.00	1.10	1.10	0.00	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.89	8.97	0.64	0.00	0.64	1.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	15.62	10.91	0.50	0.00	1.74	1.98	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	13.92	13.92	0.70	0.00	2.09	2.78	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	11.05	0.00	0.00	4.42	4.42	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	18.46	12.65	2.05	0.00	1.37	3.08	2.05	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	12.69	10.07	0.00	0.00	0.88	0.88	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	12.07	4.97	0.36	0.00	1.42	1.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	22.16	14.31	0.00	0.00	1.68	2.81	0.84	0.84	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	14.55	9.98	1.25	0.00	1.66	3.33	0.42	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	15.15	11.65	0.58	0.00	1.75	1.75	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	27.45	11.46	0.60	0.00	2.11	4.52	2.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	16.70	11.27	1.67	0.00	2.50	1.25	1.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	21.24	12.01	0.00	0.00	1.85	4.62	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	18.21	10.24	1.14	0.00	3.41	3.98	0.57	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	19.90	13.54	1.24	0.00	2.76	3.04	0.55	0.28	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	22.81	8.55	1.30	0.00	1.30	2.85	1.55	0.78	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	17.16	9.01	0.86	0.00	1.72	3.00	0.86	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.89	10.80	1.27	0.00	1.91	2.54	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	23.22	8.01	0.80	0.00	1.33	2.40	0.00	0.53	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	21.85	6.59	1.80	0.00	1.50	2.69	0.90	0.30	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	18.93	9.75	0.28	0.00	1.70	1.55	0.57	0.71	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	28.03	8.28	0.00	0.00	1.59	1.91	0.32	0.32	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	16.81	12.38	0.22	0.00	1.11	1.77	0.66	0.66	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	16.31	6.07	0.76	0.00	2.28	1.14	0.00	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	21.31	11.65	1.42	0.00	2.84	1.70	0.85	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	18.19	14.50	1.72	0.00	0.98	2.46	1.23	0.25	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	10.43	9.78	1.30	0.00	0.65	3.26	0.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	25.87	11.17	0.88	0.00	1.18	1.47	0.88	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	16.43	10.38	2.59	0.00	0.58	0.86	0.00	1.15	1.15
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	26.38	14.43	2.06	0.00	4.53	5.36	0.41	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	29.48	12.80	0.89	0.30	2.68	2.38	0.60	0.00	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	11.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	23.17	10.69	0.00	0.00	3.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	33.19	14.46	1.31	0.00	1.31	2.96	2.30	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	18.94	5.26	0.00	0.00	3.16	1.05	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	26.89	11.86	0.99	0.00	1.58	1.19	0.99	0.40	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	18.63	18.63	0.93	0.00	4.66	6.52	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	21.41	12.77	1.13	0.00	1.88	1.13	0.75	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	18.91	18.11	2.66	0.00	1.60	2.13	1.07	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	25.11	12.44	1.13	0.00	1.47	0.90	0.57	0.34	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	15.47	11.79	0.74	0.00	1.47	1.47	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	27.48	14.66	0.73	0.00	1.10	2.20	1.83	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	29.56	7.78	3.11	0.00	0.00	3.11	3.11	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	4.81	1.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	3.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	19.19	14.14	2.02	0.00	1.01	0.00	5.05	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	6.32	4.64	0.42	0.00	1.26	1.26	0.84	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1.36	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.18	0.00	0.00	0.00	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1.62	0.00	0.00	0.00	0.00	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	1.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	5.71	0.00	0.00	0.00	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	16.31	0.00	0.00	0.00	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	14.26	4.75	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00	0.00	0.00	0.00	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	10.77	5.39	1.72	0.00	0.22	0.43	0.43	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	16.72	6.27	3.66	0.00	0.52	0.52	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	6.67	3.34	2.00	0.00	0.67	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	9.18	0.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	8.18	2.85	0.38	0.19	0.00	0.38	0.57	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	9.58	1.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.12	3.40	1.36	0.00	0.00	0.68	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	6.70	2.93	0.42	0.00	0.00	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	4.42	2.32	0.93	0.00	0.23	0.00	0.23	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	21.62	8.92	2.70	0.00	0.54	0.00	0.81	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	11.77	4.84	2.73	0.00	0.21	0.00	0.63	0.00	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	2.48	2.48	0.00	0.00	0.00	0.50	0.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	7.58	1.89	1.35	0.00	0.27	0.27	0.54	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	8.84	6.35	1.81	0.00	0.00	0.00	0.91	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	20.09	7.68	2.12	0.00	0.65	0.49	0.49	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	16.59	7.29	2.19	0.00	0.73	0.36	2.37	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	11.67	3.71	2.65	0.00	0.00	0.53	1.06	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.60	4.20	1.80	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	11.49	2.63	1.97	0.00	0.00	0.33	0.00	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	6.83	4.07	1.79	0.00	0.00	0.49	0.33	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	16.40	10.05	3.88	0.00	1.06	0.18	1.41	0.35	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	6.33	4.92	0.70	0.00	0.70	0.70	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	9.65	4.60	2.76	0.00	0.00	0.00	0.92	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	15.10	8.03	1.61	0.00	0.32	0.64	0.32	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	6.90	1.03	1.03	0.00	0.00	0.00	2.07	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	17.70	12.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	11.58	6.68	3.34	0.00	0.45	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	9.74	5.50	0.85	0.00	0.42	0.00	1.27	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	7.60	3.09	1.42	0.00	0.24	0.00	0.47	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	9.44	6.87	0.86	0.00	0.00	0.00	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	9.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	15.66	9.00	3.33	0.00	0.67	0.00	0.67	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	8.12	4.96	3.61	0.00	0.90	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	5.56	2.78	2.38	0.00	0.00	0.40	0.40	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	7.43	7.43	0.93	0.00	0.93	0.00	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	6.81	3.78	1.14	0.00	0.38	0.00	0.76	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	5.21	2.93	2.28	0.00	0.33	0.65	0.65	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	11.77	7.84	6.54	0.00	0.00	0.00	0.44	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	6.78	7.24	2.71	0.00	0.45	0.90	0.00	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.94	5.29	0.88	0.00	0.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.30	4.65	3.99	0.00	0.66	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	11.91	7.94	1.98	0.00	0.50	0.00	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	5.36	4.21	2.68	0.00	1.15	0.38	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	11.19	6.05	2.12	0.00	1.81	0.30	0.91	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	6.41	4.86	3.32	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.81	3.39	2.03	0.00	0.00	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	6.71	9.15	2.44	0.00	1.22	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	5.04	2.52	2.20	0.00	0.00	0.00	0.31	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	16.04	8.47	3.63	0.00	0.30	0.30	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	6.33	7.91	0.79	0.00	0.00	0.79	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	4.53	1.13	2.27	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	4.60	3.85	1.12	0.00	0.62	0.25	0.25	0.00	0.00
Myoblast, donor2	11322-117D8	13.23	6.33	1.34	0.00	0.58	0.38	0.96	0.00	0.00
Myoblast, donor3	11398-118D3	9.08	7.06	2.19	0.00	1.01	1.01	0.34	0.50	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	92.67	16.20	1.75	1.46	0.88	0.44	1.46	0.15	0.44
Natural Killer Cells, donor1	11230-116C6	230.64	159.91	2.46	0.31	3.38	4.31	5.84	18.14	2.46
Natural Killer Cells, donor2	11311-117C6	213.80	170.08	3.02	1.21	3.02	5.13	15.08	14.47	1.81
Natural Killer Cells, donor3	11387-118C1	189.76	148.35	3.50	0.55	2.76	3.68	4.05	9.75	2.76
Neural stem cells, donor1	11275-116H6	54.08	21.78	13.79	0.00	1.09	0.73	0.73	1.45	0.00
Neural stem cells, donor2	11352-117H2	42.36	26.96	3.85	0.00	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	44.38	19.34	12.52	0.00	1.14	2.28	1.14	2.28	1.14
Neurons, donor2	11574-120E8	23.78	15.85	9.25	0.00	0.00	0.00	0.88	0.66	0.00
Neurons, donor3	11655-122E8	38.64	16.44	9.87	0.00	0.82	0.00	3.29	0.00	0.00
Neutrophils, donor1	11233-116C9	117.86	57.54	0.00	0.00	4.64	8.35	4.64	3.71	0.00
Neutrophils, donor2	11314-117C9	153.64	72.47	0.00	0.00	0.00	2.90	20.29	0.00	2.90
Neutrophils, donor3	11390-118C4	94.07	70.86	4.28	0.00	4.28	5.50	1.83	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	20.07	13.77	3.92	0.36	1.19	0.59	0.95	0.12	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	18.23	8.47	3.91	0.00	0.00	0.65	0.33	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	11.23	5.82	3.61	0.00	0.40	0.20	0.40	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	11.56	7.16	2.20	0.00	0.41	0.83	0.55	0.14	0.00
Olfactory epithelial cells, donor2	11934-125I8	12.16	9.55	2.46	0.00	0.72	0.29	2.32	0.00	0.00
Olfactory epithelial cells, donor3	11935-125I9	9.19	6.24	1.14	0.00	0.57	0.57	0.68	0.00	0.11
Olfactory epithelial cells, donor4	11936-126A1	9.54	7.60	1.95	0.00	0.58	0.00	0.29	0.00	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	16.85	16.85	1.81	0.00	0.60	1.81	0.60	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	9.57	5.10	2.77	0.00	1.49	0.43	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	1.14	2.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	15.52	2.48	2.48	0.00	0.62	0.62	0.00	1.24	0.62
Osteoblast, donor1	11277-116H8	7.43	3.52	2.15	0.00	0.00	0.20	0.00	0.00	0.20
Osteoblast, donor2	11354-117H4	7.73	2.81	2.81	0.00	0.00	0.70	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	16.00	5.51	3.02	0.00	1.60	1.07	0.36	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	13.39	7.83	1.77	0.25	1.35	0.08	0.34	0.08	0.25
Pericytes, donor1	11491-119E6	28.26	8.23	7.90	0.00	1.11	0.33	0.56	0.33	0.33
Pericytes, donor2	11571-120E5	33.28	10.19	7.70	0.00	0.68	1.36	0.68	0.23	0.00
Pericytes, donor3	11652-122E5	16.89	6.51	1.63	0.61	0.81	1.22	1.22	0.00	0.00
Perineurial Cells, donor1	11499-119F5	9.27	4.29	1.36	0.00	0.45	0.11	0.23	0.11	0.00
Perineurial Cells, donor2	11579-120F4	13.16	6.35	1.10	0.55	1.29	0.18	0.09	0.18	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	193.16	145.98	4.14	0.00	2.23	2.55	1.59	11.47	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	165.53	102.84	2.94	0.24	2.20	5.14	10.77	5.39	2.45
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	194.77	131.23	2.85	0.26	1.55	2.59	5.56	10.09	1.68
Placental Epithelial Cells, donor1	11278-116H9	10.76	7.65	0.72	0.00	0.24	0.24	0.00	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	13.31	3.33	0.00	0.00	0.00	2.22	0.00	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	13.74	9.42	3.14	1.57	1.57	0.00	0.59	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	20.89	12.66	1.90	0.00	2.22	1.58	4.75	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	14.82	8.07	3.38	0.19	0.94	1.88	0.56	0.38	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	15.92	12.53	1.44	0.26	1.44	1.83	0.39	0.78	1.31
Preadipocyte - breast, donor2	11328-117E5	31.52	13.73	2.03	0.68	1.13	2.70	2.93	0.23	0.45
Preadipocyte - omental, donor1	11468-119C1	15.56	9.38	3.41	0.32	1.28	1.07	0.75	0.11	0.43
Preadipocyte - omental, donor2	11329-117E6	12.22	13.97	4.36	0.00	0.44	2.18	0.87	0.00	0.87
Preadipocyte - omental, donor3	11403-118D8	16.62	6.30	2.86	0.14	1.00	0.86	1.29	0.14	0.14
Preadipocyte - perirenal, donor1	11469-119C2	14.76	9.84	3.94	0.98	1.97	0.98	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	11.36	6.76	0.31	0.00	0.92	0.31	0.00	0.31	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	23.91	7.97	1.06	0.35	0.89	0.53	1.24	0.18	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	17.54	8.68	2.04	0.17	1.87	0.68	0.68	0.51	0.17
Preadipocyte - visceral, donor1	11280-116I2	18.91	10.34	1.86	0.28	1.21	0.56	0.65	0.09	0.75
Preadipocyte - visceral, donor2	11357-117H7	27.15	9.20	0.46	0.00	1.84	1.84	0.46	0.00	1.38
Preadipocyte - visceral, donor3	11429-118G7	12.02	5.22	1.46	0.10	0.73	0.31	0.21	0.00	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	48.42	14.78	1.96	0.00	1.21	0.30	1.06	0.75	0.00
Prostate Epithelial Cells, donor2	11331-117E8	17.06	8.67	1.08	0.00	0.81	0.81	1.62	0.41	0.14
Prostate Epithelial Cells, donor3	11404-118D9	24.80	21.80	1.90	0.00	2.02	1.90	1.04	0.86	0.00
Prostate Stromal Cells, donor1	11254-116F3	7.86	3.76	0.68	0.00	0.68	0.34	0.11	0.00	0.00
Prostate Stromal Cells, donor2	11332-117E9	10.76	5.56	1.26	0.18	0.72	0.18	0.72	0.00	0.00
Prostate Stromal Cells, donor3	11405-118E1	8.45	5.63	2.09	0.00	1.15	0.63	0.94	0.00	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	24.45	16.79	1.82	0.00	0.73	1.46	0.36	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	16.43	10.47	0.83	0.00	0.35	0.42	0.35	0.21	0.00
Renal Epithelial Cells, donor1	11517-119H5	20.29	4.57	1.52	0.00	0.00	0.00	0.00	0.00	1.01
Renal Epithelial Cells, donor2	11597-120H4	12.80	8.54	0.71	0.00	0.71	0.00	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	13.76	8.58	0.85	0.00	1.06	0.74	0.21	0.11	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	21.79	3.40	0.68	0.00	1.36	0.00	2.04	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	21.29	6.74	1.35	0.00	1.35	0.94	0.94	0.13	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	9.77	2.44	1.11	0.00	0.44	0.22	0.44	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	13.97	2.66	0.67	0.00	0.00	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	14.97	6.38	2.20	0.22	0.22	0.44	0.66	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	24.45	11.29	2.51	0.00	0.00	0.00	0.00	0.00	1.25
Renal Mesangial Cells, donor3	11679-122H5	16.37	9.15	3.33	0.00	0.00	0.28	0.83	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	20.94	11.81	0.54	0.00	0.54	0.27	0.00	0.27	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	14.76	9.28	2.11	0.00	0.84	0.42	0.42	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	12.15	4.82	1.16	0.00	0.00	0.39	0.96	0.00	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	5.19	4.15	1.81	0.00	0.26	0.00	0.00	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	11.09	3.98	3.70	0.00	0.00	0.00	0.28	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	2.06	2.06	5.15	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	12.29	5.77	3.26	0.25	0.00	0.00	0.50	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	52.25	21.65	4.68	6.95	2.54	3.21	0.80	0.53	1.47
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	30.38	10.72	5.36	0.89	0.89	0.89	0.89	0.89	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	27.52	8.26	1.65	0.00	0.00	1.65	1.65	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	30.16	13.92	1.74	0.00	1.74	1.16	2.32	1.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	22.75	6.50	1.82	0.00	0.26	0.13	0.78	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	31.18	9.63	3.18	0.00	0.60	0.89	2.09	0.50	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	33.68	10.93	2.12	0.00	0.67	0.78	0.45	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	33.74	8.56	2.60	0.00	0.37	0.50	1.12	0.25	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	40.91	10.84	2.33	0.00	0.47	1.05	1.75	0.35	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	39.52	13.41	3.70	0.00	0.69	0.69	2.08	0.23	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	28.20	8.49	2.33	0.00	0.41	0.27	0.82	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	32.98	9.98	3.18	0.00	0.30	0.45	1.97	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	33.87	10.39	3.23	0.00	1.08	0.90	0.54	0.54	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	31.70	8.46	2.30	0.00	0.14	0.72	1.00	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	39.17	11.16	3.43	0.00	0.43	0.86	2.04	0.11	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	38.94	8.63	4.87	0.00	0.66	0.44	0.66	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	30.40	8.41	1.53	0.00	0.38	0.96	0.57	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	34.19	10.81	3.07	0.00	0.56	0.37	1.21	0.37	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	40.96	13.91	3.01	0.00	0.94	0.75	0.94	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	31.19	9.55	3.18	0.00	0.93	1.06	0.53	0.13	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	41.27	11.39	3.02	0.00	0.97	0.68	1.17	0.58	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	46.40	9.17	4.01	0.00	0.76	1.15	0.95	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	33.64	9.82	2.67	0.00	0.21	1.39	0.53	0.64	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	38.12	13.45	2.24	0.00	0.28	0.56	1.12	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	45.80	12.82	3.08	0.00	0.51	0.85	1.71	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	36.65	10.03	2.92	0.00	0.36	0.36	0.91	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	43.41	12.88	3.80	0.00	0.74	0.74	2.45	0.49	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	47.95	11.55	4.30	0.00	0.27	1.34	1.07	0.54	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	48.35	10.61	3.30	0.00	1.18	0.94	1.18	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	42.26	17.26	4.76	0.00	0.60	1.19	4.56	0.99	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	43.03	13.10	6.31	0.00	0.70	0.70	1.64	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	36.08	11.61	2.49	0.00	0.00	0.62	1.04	0.41	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	39.15	15.93	3.32	0.00	0.66	0.88	3.76	0.88	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	47.83	13.79	4.80	0.00	0.42	0.42	0.84	0.63	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	39.43	11.04	3.90	0.00	0.54	1.35	1.75	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	35.25	15.33	2.90	0.00	0.17	1.02	0.68	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	40.29	12.92	3.28	0.00	1.54	1.16	0.58	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	28.89	10.32	3.09	0.00	0.86	0.69	0.86	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	23.32	8.50	3.29	0.00	1.23	0.96	0.55	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	33.00	9.85	3.12	0.00	0.82	0.99	1.81	0.16	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	26.93	10.23	2.39	0.00	0.68	0.34	0.34	0.00	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	36.40	10.80	3.40	0.00	0.89	0.89	1.33	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	35.72	13.33	2.67	0.00	1.33	1.60	0.80	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	54.62	11.75	6.08	0.00	0.83	0.83	0.69	0.28	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	60.72	12.14	4.05	0.00	0.24	1.19	1.43	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	64.09	19.55	6.25	0.00	1.41	1.01	0.20	0.00	1.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	63.85	16.76	4.61	0.00	0.57	1.41	1.60	0.28	1.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	61.49	18.87	8.73	0.00	0.35	1.75	2.10	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	42.01	13.30	7.25	0.00	1.51	0.30	0.60	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	51.16	17.50	3.67	0.00	0.98	0.61	1.35	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	79.76	36.10	9.02	0.00	2.33	3.06	1.02	1.46	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	55.98	18.25	6.69	0.00	0.00	1.83	1.83	0.61	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	47.32	16.58	5.73	0.00	0.90	0.60	2.11	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	68.99	19.90	7.69	0.00	1.36	1.58	2.94	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	70.09	28.16	5.69	0.00	0.60	0.90	2.70	0.60	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	42.15	13.70	3.90	0.00	1.18	0.94	1.65	0.59	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	55.71	20.06	8.75	0.21	2.13	1.49	0.85	0.43	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	55.89	21.03	4.21	0.00	1.80	1.80	0.60	0.60	0.00
Schwann Cells, donor1	11498-119F4	25.58	10.34	2.63	0.19	0.56	0.38	1.32	0.00	0.19
Schwann Cells, donor2	11578-120F3	13.61	6.80	0.00	0.00	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	25.85	9.42	1.10	0.00	0.66	0.00	0.44	0.00	0.00
Sebocyte, donor1	11220-116B5	58.61	25.20	1.10	0.00	4.38	2.19	0.55	3.29	1.10
Sebocyte, donor2	11301-117B5	30.33	19.76	0.46	0.46	2.30	1.38	2.30	0.46	0.46
Sebocyte, donor3	11378-118B1	37.10	12.37	2.27	0.41	1.65	1.65	0.62	0.62	0.62
Sertoli Cells, donor1	11255-116F4	6.63	8.28	3.31	0.00	0.00	1.66	1.66	0.00	1.66
Sertoli Cells, donor2	11333-117F1	2.82	2.82	2.82	0.00	5.65	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	24.19	8.09	1.58	0.00	0.79	0.09	0.70	0.26	0.00
Skeletal Muscle Cells, donor2	11358-117H8	12.29	2.17	0.72	0.00	0.00	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	10.87	2.51	1.67	0.00	0.00	0.00	0.00	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	13.82	5.03	0.94	0.47	0.16	0.31	0.47	0.00	0.31
Skeletal Muscle Cells, donor5	11455-119A6	16.80	4.76	1.19	0.59	0.30	0.15	0.45	0.30	0.45
Skeletal Muscle Cells, donor6	11459-119B1	16.47	5.39	0.77	0.00	0.46	0.31	0.31	0.00	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	22.05	11.59	1.76	2.27	1.13	0.76	0.88	0.25	1.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	20.12	10.42	2.00	0.29	0.86	0.14	1.00	0.29	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	17.26	7.34	0.99	0.20	0.50	0.20	0.89	0.00	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	19.29	7.58	2.19	0.00	0.59	0.17	0.17	0.25	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	10.86	2.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	6.88	4.13	1.51	0.00	0.28	0.00	0.83	0.14	0.00
Skin - palm, donor1	10286-104F7	24.17	83.27	10.74	0.00	5.37	10.74	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	22.34	14.70	0.58	0.00	0.58	0.29	0.58	0.43	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	34.35	18.81	0.82	0.00	1.64	0.82	3.27	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	29.73	11.17	0.65	0.00	1.17	1.30	2.21	0.78	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	28.36	18.21	1.39	0.00	1.39	2.22	1.53	1.11	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	44.31	19.83	0.98	0.00	2.95	3.09	2.53	1.41	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	28.55	16.49	0.63	0.00	1.27	0.63	0.63	0.42	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	56.74	33.13	1.80	0.00	2.55	3.30	1.80	1.20	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	10.18	4.01	2.47	0.00	2.47	0.93	2.16	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	5.78	7.78	1.11	0.00	1.11	0.00	0.00	0.44	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	9.99	5.88	0.59	0.00	0.00	0.00	0.00	0.00	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	10.83	5.52	1.10	0.00	0.66	0.44	0.00	0.22	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	6.69	5.12	0.79	0.00	0.39	0.39	0.00	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	5.41	5.41	1.55	0.00	0.00	0.77	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	17.01	10.01	0.00	1.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	7.59	3.19	0.67	0.00	0.40	0.13	0.00	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	7.98	7.98	2.44	0.00	0.66	0.44	1.11	0.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	5.38	3.07	0.77	0.13	0.64	0.38	0.38	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	15.30	4.56	1.63	0.33	0.33	0.00	0.00	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	9.45	5.91	2.95	0.00	0.89	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	7.83	4.98	1.00	0.00	0.14	0.28	0.28	0.14	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	18.71	9.92	2.77	0.16	0.49	0.49	0.33	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	23.14	15.53	4.57	1.22	1.83	1.22	0.61	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	8.59	3.28	1.77	0.25	0.51	0.00	0.00	0.00	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	42.84	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.29	2.86	0.48	0.00	0.00	0.48	0.00	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	9.14	5.46	1.47	0.44	0.59	0.44	0.00	0.00	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	10.76	7.32	1.51	1.08	0.22	0.22	1.29	0.00	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	9.87	5.67	0.84	0.21	0.21	0.10	0.21	0.10	0.84
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	7.12	4.80	0.77	0.00	1.39	0.15	0.00	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	5.39	3.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	12.85	5.08	0.90	0.00	0.90	0.00	0.30	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	10.58	6.49	2.05	0.68	0.68	0.00	0.34	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	8.64	5.73	0.71	0.31	0.24	0.08	0.24	0.16	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	12.08	10.06	3.32	0.00	1.11	0.81	0.81	0.70	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	7.74	3.87	0.91	0.00	0.68	0.46	0.46	0.46	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	8.45	7.25	1.21	0.00	1.21	1.21	0.00	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	4.50	0.53	1.06	0.53	0.26	0.00	0.00	0.00	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	7.06	2.13	1.20	0.00	0.27	0.40	0.13	0.00	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	6.39	2.88	0.88	0.00	0.25	0.13	0.63	0.00	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	17.25	11.41	4.06	0.00	2.28	1.01	0.25	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	10.10	7.54	1.66	0.00	0.90	0.60	0.15	0.15	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	10.50	4.50	1.50	0.75	0.00	2.25	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	109.84	32.31	11.63	0.00	1.29	0.00	1.29	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	4.19	3.72	0.00	0.00	0.47	0.47	0.00	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	4.54	5.05	0.50	0.00	0.00	0.50	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	4.39	1.57	0.94	0.00	0.63	0.31	0.63	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	12.39	8.26	1.18	0.88	1.47	0.59	0.00	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	10.50	6.50	0.92	0.25	0.50	0.33	0.08	0.08	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	23.36	19.62	4.67	1.87	0.47	0.47	0.93	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	5.18	1.87	0.58	0.00	0.14	0.29	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	9.94	5.10	1.27	0.00	0.51	0.76	0.00	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	7.52	3.57	0.75	0.00	0.38	0.19	0.38	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	13.00	3.63	0.84	0.42	0.84	0.14	0.42	0.14	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	9.80	8.55	1.01	0.00	0.92	0.34	0.42	0.08	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	13.33	5.24	1.90	0.00	0.00	0.48	0.00	0.00	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	4.89	1.22	0.73	0.00	0.49	0.24	0.00	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	5.74	3.31	1.10	0.00	0.44	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	3.51	1.76	0.59	0.29	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	16.72	8.16	2.92	0.00	0.19	0.19	1.36	0.19	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	7.14	2.38	1.06	0.00	0.26	0.53	1.06	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	6.32	4.46	0.00	0.00	0.37	0.37	1.49	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	8.26	4.31	0.72	0.36	1.44	0.72	0.36	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	5.96	3.69	0.85	0.00	0.28	0.57	0.85	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	10.63	4.73	1.18	0.39	0.39	0.00	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	6.86	5.84	0.51	0.25	0.76	0.00	0.25	0.00	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	10.78	5.99	0.80	0.00	0.80	0.40	0.40	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	8.78	5.85	2.09	0.00	0.42	0.42	1.67	0.42	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	11.92	10.54	2.29	0.00	1.38	0.00	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	31.48	24.24	3.20	0.00	3.03	3.03	0.67	2.02	0.00
Synoviocyte, donor2	11368-117I9	9.55	11.90	3.52	0.17	1.34	1.01	0.17	0.34	0.17
Synoviocyte, donor3	11440-118H9	6.48	12.51	3.13	0.00	1.34	1.34	0.22	0.89	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	26.44	8.58	1.07	0.71	0.36	0.00	0.36	0.00	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	17.84	7.93	0.00	3.96	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	25.47	5.56	0.93	0.23	0.23	0.00	0.46	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	20.07	10.32	0.50	0.07	0.93	0.57	0.00	0.43	0.43
Tracheal Epithelial Cells, donor2	11369-118A1	10.05	6.96	0.39	0.00	0.39	0.00	0.77	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	10.88	2.86	0.00	0.00	0.00	1.15	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	55.98	21.28	5.41	7.63	2.21	3.20	1.23	0.62	1.72
Urethra, donor2	10319-105A4	23.38	12.59	14.39	1.80	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	22.85	24.44	0.00	0.00	1.33	1.06	0.27	0.80	0.00
Urothelial Cells, donor2	11600-120H7	17.22	16.82	0.80	0.00	1.60	0.40	1.60	0.80	0.00
Urothelial Cells, donor3	11681-122H7	15.82	16.50	0.92	0.00	0.46	0.46	0.69	1.38	0.23
Urothelial cells, donor0	11216-116B1	20.06	22.07	0.67	0.00	1.78	0.89	0.22	0.00	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	110.33	67.62	9.79	0.89	7.12	7.12	2.67	1.78	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	97.21	68.62	12.87	0.00	7.15	15.73	1.43	5.72	5.72
Whole blood (ribopure), donor090309, donation3	12181-129A3	115.68	68.45	7.53	0.00	2.74	6.16	7.53	1.37	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	111.22	65.77	4.48	0.34	4.13	5.17	0.69	3.10	1.72
Whole blood (ribopure), donor090325, donation2	12177-128I8	97.61	74.95	3.49	0.58	2.32	2.91	2.91	1.16	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	101.00	61.43	12.49	0.00	5.21	8.33	2.08	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	121.15	61.49	9.18	0.00	2.75	11.93	1.84	0.92	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	101.33	60.25	9.13	0.00	4.56	6.39	3.65	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	4.56	1.23	0.25	0.00	0.12	0.00	0.00	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	12.32	3.52	2.64	0.00	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	10.61	9.50	1.40	0.00	0.56	0.84	0.28	0.00	0.00
achilles tendon, donor2	10292-104G4	28.93	16.53	4.13	0.00	0.00	6.20	0.00	2.07	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	37.99	5.35	0.76	0.00	0.00	0.25	0.76	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	31.11	6.04	0.93	0.00	0.00	0.23	0.46	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	71.94	15.55	2.02	0.59	0.36	0.12	0.83	0.12	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	38.37	3.54	2.18	0.00	0.27	0.00	1.63	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	40.76	2.81	2.53	0.56	0.56	0.00	0.84	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	54.14	5.50	2.33	0.21	0.42	1.06	0.21	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	103.44	11.98	7.35	1.09	0.27	1.91	2.99	0.27	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	3.97	0.44	0.44	0.00	0.44	0.88	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	64.93	11.03	2.04	0.41	0.00	0.82	3.27	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	39.22	8.93	3.49	0.00	0.00	0.00	0.78	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	32.75	5.15	1.66	0.37	0.18	0.18	0.74	0.37	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	27.30	11.70	3.90	0.00	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	64.60	8.83	2.09	0.93	0.23	0.70	1.39	0.70	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	79.48	6.21	7.77	0.00	0.00	0.26	1.04	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	55.23	6.43	5.84	0.00	0.88	0.58	1.46	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	37.65	5.11	1.86	0.00	0.93	0.00	1.39	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	34.55	8.23	1.65	0.00	0.41	0.82	0.41	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	23.02	3.07	3.99	0.00	0.00	0.61	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	37.98	4.27	2.56	0.00	0.00	0.85	0.43	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	42.76	5.76	3.64	0.00	0.00	1.21	0.30	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	40.92	6.98	3.61	0.00	0.96	0.72	0.48	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	35.64	7.13	0.89	0.22	0.45	0.67	1.11	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	23.35	8.01	1.33	0.67	0.67	1.33	0.67	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	7.43	1.86	1.86	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	52.36	3.77	3.39	0.75	0.38	0.38	0.38	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	25.73	4.80	4.80	0.44	1.74	0.44	0.44	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	28.12	0.00	0.00	0.00	0.00	3.75	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	36.74	23.31	0.94	0.00	2.35	1.41	0.47	0.94	0.00
adipose tissue, adult, pool1	10010-101C1	33.51	20.01	5.89	3.72	3.10	2.02	0.31	0.78	0.62
adipose, donor1	10184-103D4	9.38	2.93	0.00	0.00	1.17	0.00	0.59	0.00	0.00
adipose, donor2	10185-103D5	17.44	8.52	3.65	0.00	0.81	0.00	0.41	0.41	0.81
adipose, donor3	10186-103D6	17.15	10.07	3.81	0.00	0.00	0.27	0.27	0.54	0.27
adipose, donor4	10187-103D7	35.54	13.00	8.67	0.00	0.00	0.00	0.87	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	17.36	4.42	2.84	0.00	0.47	0.63	0.47	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	14.55	3.64	0.00	0.00	0.00	3.64	0.00	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	26.28	6.00	1.07	0.00	0.40	0.13	0.27	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	8.93	1.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	16.46	19.94	1.85	0.00	5.10	2.78	0.46	1.16	0.00
amniotic membrane cells, donor2	12236-129G4	11.83	7.78	3.38	0.00	1.01	0.00	0.34	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	6.19	19.15	2.95	0.29	2.06	0.88	0.29	0.88	0.00
amygdala - adult, donor10196	10167-103B5	16.60	18.97	14.23	4.74	0.00	1.19	2.37	1.19	0.00
amygdala, adult, donor10252	10151-102I7	42.99	30.01	30.82	16.83	1.01	1.82	3.24	1.01	0.20
amygdala, newborn, donor10223	10360-105E9	24.85	17.11	11.94	1.61	1.29	1.94	0.65	0.32	3.87
anaplastic carcinoma cell line:8305C	10428-106D5	22.66	10.95	1.15	0.00	1.27	0.25	0.25	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	28.46	2.65	1.32	0.22	0.88	0.22	0.44	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	20.71	20.38	5.68	0.00	0.33	0.67	0.33	0.33	0.33
aorta, adult, pool1	10052-101G7	24.32	22.16	11.96	1.77	1.77	0.59	1.57	0.20	1.77
appendix, adult	10189-103D9	48.90	22.12	5.43	0.78	1.55	0.39	0.00	1.16	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	16.51	2.41	1.72	0.00	0.00	0.00	0.69	0.00	0.00
artery, adult	10190-103E1	21.74	19.02	6.79	19.02	2.72	6.79	2.72	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	11.73	3.62	3.04	0.00	0.58	0.00	0.29	0.00	0.00
b cell line:RPMI1788	10427-106D4	72.42	11.15	1.49	0.15	0.00	0.30	0.59	0.45	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	8.32	6.94	1.94	0.00	0.55	1.11	0.83	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	5.95	1.49	0.50	0.00	0.10	0.10	0.10	0.00	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	24.10	8.87	1.17	0.00	1.00	0.33	1.34	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	69.90	6.71	2.24	0.00	1.68	1.68	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	18.14	15.54	4.35	1.30	1.74	0.54	0.65	0.33	0.43
blood, adult, pool1	10053-101G8	95.23	37.65	4.43	0.00	2.21	8.86	4.43	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.13	2.57	0.86	0.00	2.57	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	42.51	21.59	5.40	2.02	0.67	2.02	3.37	0.67	0.67
brain, adult, donor1	10084-102B3	34.85	17.43	23.58	5.13	1.03	2.05	0.00	1.03	2.05
brain, adult, pool1	10012-101C3	28.17	37.31	13.92	12.14	2.23	2.23	1.22	2.34	3.34
brain, fetal, pool1	10085-102B4	24.04	10.69	13.36	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	6.28	3.30	0.99	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	6.12	0.25	6.24	0.00	0.12	0.00	0.12	0.00	0.00
breast, adult, donor1	10080-102A8	31.57	13.89	0.63	1.26	0.63	1.26	0.00	0.00	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	27.69	12.07	1.40	0.00	0.89	0.25	0.64	0.13	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	7.42	4.95	0.31	0.00	0.62	0.00	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	7.83	7.14	0.00	0.00	0.46	0.00	1.15	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	10.17	7.75	1.45	0.00	0.48	0.00	0.73	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	46.55	13.63	2.35	0.00	0.00	0.00	0.00	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	17.28	7.22	0.77	0.00	0.22	0.55	0.44	0.11	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	16.48	9.19	0.95	0.00	0.00	0.00	0.63	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	37.26	21.29	5.59	0.00	0.53	1.33	1.06	0.80	0.00
caudate nucleus - adult, donor10196	10177-103C6	28.78	23.03	17.27	31.09	1.15	1.15	2.30	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	20.92	25.60	24.93	25.60	0.00	1.17	1.51	1.34	0.33
caudate nucleus, adult, donor10258	10379-105H1	21.40	12.23	28.27	14.52	0.00	0.00	0.76	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	12.82	13.92	15.02	3.66	0.73	2.20	1.46	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	2.91	37.87	52.44	131.10	5.83	2.91	0.00	2.91	20.39
cerebellum, adult, donor10252	10166-103B4	36.72	29.25	91.17	90.96	2.56	3.63	2.99	1.07	20.92
cerebellum, adult, pool1	10083-102B2	27.94	30.01	38.63	20.01	3.10	4.48	1.38	1.72	7.24
cerebellum, newborn, donor10223	10357-105E6	35.70	29.89	24.91	0.00	4.15	3.32	1.66	2.49	4.15
cerebral meninges, adult	10188-103D8	17.90	18.15	15.38	13.62	2.27	1.51	1.51	0.76	2.02
cerebrospinal fluid, donor2	10294-104G6	8.77	5.85	2.19	7.31	1.46	0.73	0.00	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	28.61	25.45	2.59	0.00	2.73	3.88	0.14	2.16	0.00
cervical cancer cell line:ME-180	10553-107I4	61.32	57.17	3.48	0.00	4.64	7.46	0.83	2.65	0.17
cervix, adult, pool1	10013-101C4	31.29	21.10	8.61	3.04	2.31	1.68	1.36	1.36	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	12.82	6.97	0.14	0.00	0.84	0.28	0.28	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	9.14	3.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	23.36	3.85	1.37	0.00	0.00	0.12	0.37	0.62	0.00
choriocarcinoma cell line:SCH	10785-110H2	11.83	3.45	0.49	0.12	0.00	0.12	0.25	0.37	0.86
choriocarcinoma cell line:T3M-3	10618-108G6	28.46	3.08	1.42	0.00	0.00	0.47	0.24	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	10.26	9.97	2.28	0.00	2.28	0.57	0.28	0.85	0.00
chorionic membrane cells, donor2	12239-129G7	12.53	6.16	0.60	0.10	0.30	0.50	0.50	0.10	0.20
chorionic membrane cells, donor3	12240-129G8	12.64	6.04	0.00	0.55	2.20	1.10	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	51.50	14.14	2.02	1.01	0.00	0.00	4.04	2.02	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	21.71	4.03	0.96	0.58	0.19	0.19	0.96	0.19	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	20.91	7.60	2.32	0.00	1.06	0.21	0.21	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	6.93	1.03	0.51	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	5.56	2.18	1.21	0.24	0.24	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	6.31	1.63	0.20	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	7.95	2.36	0.88	0.00	0.59	0.00	0.29	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	41.18	5.73	3.91	0.26	1.04	1.30	0.52	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	5.94	4.80	0.46	0.00	0.23	0.23	0.23	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	8.68	4.51	0.52	0.00	0.69	0.35	0.17	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	8.79	2.56	0.73	0.00	0.37	0.37	0.18	0.00	0.00
colon carcinoma cell line:COLO-320	10420-106C6	15.20	3.04	1.52	0.00	0.38	0.00	0.76	0.38	0.00
colon, adult, donor1	10082-102B1	27.37	29.75	9.52	1.19	4.76	1.19	1.19	0.00	1.19
colon, adult, pool1	10014-101C5	50.41	25.62	7.05	0.94	3.53	4.70	0.82	0.24	2.94
colon, fetal, donor1	10070-101I7	22.25	15.45	3.09	0.00	2.47	1.85	1.24	0.62	3.09
common myeloid progenitor CMP, donor1	12130-128D6	91.67	68.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	37.39	12.75	0.00	0.00	0.42	0.42	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	39.54	14.04	0.45	0.00	0.75	0.45	0.45	0.30	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	30.74	11.84	0.28	0.00	1.27	0.42	0.85	0.42	0.14
corpus callosum, adult, pool1	10042-101F6	90.99	96.41	23.88	0.77	5.42	6.85	1.66	8.18	1.00
cruciate ligament, donor2	10295-104G7	21.07	13.78	5.67	1.62	4.05	2.43	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	17.66	12.04	3.21	1.61	2.41	2.41	0.80	0.00	0.00
diencephalon, adult	10193-103E4	24.48	21.12	13.92	3.36	0.48	2.40	1.20	0.96	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	38.57	4.59	0.00	0.23	0.00	0.00	3.44	0.46	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	6.41	4.62	1.03	0.00	0.00	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	18.78	6.74	1.44	0.00	0.48	0.00	0.24	0.00	0.00
ductus deferens, adult	10196-103E7	43.85	18.44	9.97	1.50	2.49	2.99	0.50	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	24.48	11.52	4.32	0.00	1.44	0.00	1.44	0.00	7.20
duodenum, fetal, donor1, tech_rep2	10071-101I8	46.35	21.33	8.83	0.00	3.68	0.74	2.94	1.47	6.62
dura mater, adult, donor1	10041-101F5	42.78	30.47	10.98	0.83	2.89	3.06	1.24	0.99	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	2.89	1.11	0.22	0.00	0.22	0.22	0.00	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	9.31	1.00	0.86	0.00	0.00	0.14	0.29	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	14.80	4.32	0.62	0.00	1.85	0.62	1.23	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	15.14	6.36	1.21	0.00	0.30	0.30	0.30	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	17.60	5.25	1.23	0.00	1.23	0.00	0.31	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	18.39	6.57	1.31	0.00	1.31	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	4.36	0.00	0.67	0.00	0.00	0.34	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	31.35	10.15	3.26	0.00	1.45	0.54	1.27	0.36	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	5.95	2.09	1.29	0.00	0.16	0.16	0.80	0.16	0.00
epidermoid carcinoma cell line:A431	10426-106D3	57.91	64.69	4.34	0.11	5.22	5.34	1.45	2.89	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	18.81	6.49	0.55	0.00	0.22	0.33	0.33	0.00	0.00
epididymis, adult	10197-103E8	24.91	16.54	9.84	2.09	2.51	1.88	0.21	0.63	1.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	11.53	13.66	0.89	0.00	0.89	0.35	0.35	0.18	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	5.51	1.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	30.80	18.35	2.36	0.00	1.70	0.92	1.05	0.13	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	34.64	23.62	2.56	0.00	0.89	2.36	1.57	0.20	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	29.46	20.84	0.56	0.00	1.34	1.12	0.45	0.45	0.00
esophagus, adult, pool1	10015-101C6	21.77	18.90	4.99	2.02	3.50	2.02	0.64	0.42	1.38
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	3.88	1.88	2.38	0.00	0.00	0.00	0.13	0.25	0.00
eye - muscle inferior rectus, donor1	10272-104E2	28.97	31.39	4.83	19.32	0.00	12.07	2.41	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	21.04	12.63	0.00	14.73	0.00	0.00	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	10.42	11.91	5.95	16.37	0.00	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	29.81	14.90	4.59	11.46	3.44	3.44	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	24.78	16.03	2.91	2.91	1.46	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	11.69	13.47	4.58	2.54	1.27	1.27	0.00	0.00	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	6.28	2.31	0.26	0.00	0.13	0.13	0.13	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	14.01	3.56	1.19	0.00	0.24	0.24	0.47	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	37.90	45.32	27.21	15.11	2.35	3.10	1.22	2.72	2.53
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	16.51	15.31	1.20	0.00	2.40	1.50	0.30	0.90	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	10.24	9.51	0.09	0.00	0.73	0.00	0.27	0.00	0.18
gall bladder, adult	10198-103E9	35.73	21.49	9.90	3.14	2.66	3.14	0.97	0.97	0.24
gamma delta positive T cells, donor1	11937-126A2	144.95	90.73	2.68	0.54	2.15	3.76	6.44	6.44	1.61
gamma delta positive T cells, donor2	11938-126A3	123.63	85.16	1.49	0.00	1.87	3.36	2.99	6.35	4.11
gastric adenocarcinoma cell line:MKN1	10614-108G2	21.33	12.04	3.38	0.00	0.63	2.96	2.32	0.63	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	49.32	24.76	0.97	0.00	1.35	1.93	0.97	1.16	0.19
gastric cancer cell line:AZ521	10549-107H9	18.20	8.20	0.98	0.00	0.82	0.00	0.98	0.49	0.00
gastric cancer cell line:GSS	10560-108A2	23.80	15.56	6.41	0.00	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	74.48	15.31	3.88	0.00	0.23	0.91	5.71	0.46	0.00
giant cell carcinoma cell line:LU65	10487-107B1	20.31	8.15	0.57	0.00	0.69	0.23	0.57	0.23	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	31.35	18.33	1.54	0.00	0.70	0.98	0.42	0.14	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	34.67	24.44	1.75	0.25	3.74	2.74	1.25	0.75	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	10.03	4.64	1.79	0.00	1.37	0.42	0.00	0.11	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	9.13	6.74	1.54	0.00	0.28	0.42	0.14	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	12.47	7.17	1.21	0.00	0.55	0.33	0.22	0.11	0.00
glioma cell line:GI-1	10413-106B8	11.13	7.91	0.59	0.00	0.00	0.59	0.59	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	43.73	38.63	8.02	8.75	0.00	1.46	1.46	4.37	0.73
globus pallidus, adult, donor10252	10161-103A8	100.08	71.03	20.75	5.37	4.64	8.30	3.17	6.10	0.98
globus pallidus, adult, donor10258	10367-105F7	41.08	28.75	8.22	1.37	1.37	6.85	2.74	8.22	0.00
globus pallidus, newborn, donor10223	10364-105F4	32.51	13.86	13.32	1.60	1.07	1.07	1.60	1.60	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	127.25	51.39	4.89	0.00	4.89	2.45	0.00	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	10.93	0.00	0.00	0.00	0.00	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	5.23	0.00	0.00	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	13.76	7.04	0.96	0.00	0.32	0.64	0.64	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	15.15	2.30	1.84	0.46	0.00	0.00	0.46	0.00	1.84
hIPS +CCl2, biol_rep2	14384-156C1	17.83	1.37	1.83	0.00	0.00	0.00	0.46	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	18.03	0.00	1.93	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	10.06	1.44	0.00	0.00	1.44	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	14.40	1.37	2.06	0.00	0.00	0.00	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	19.86	15.45	5.52	8.83	1.10	1.10	0.00	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	47.70	11.49	0.86	0.00	0.86	0.29	0.29	0.29	0.00
heart - mitral valve, adult	10205-103F7	23.92	23.92	5.38	8.07	4.19	2.69	0.90	0.90	1.79
heart - pulmonic valve, adult	10206-103F8	41.05	29.02	7.32	8.37	3.40	2.88	1.05	0.26	1.31
heart - tricuspid valve, adult	10207-103F9	24.98	5.83	4.16	0.83	0.83	1.67	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	23.87	11.43	2.86	6.12	1.22	0.20	0.82	0.00	0.20
heart, adult, diseased, donor1	10051-101G6	38.75	14.05	6.39	13.63	2.13	0.00	2.98	0.43	0.85
heart, adult, pool1	10016-101C7	30.59	12.19	4.60	8.74	1.84	2.30	0.23	0.69	0.69
heart, fetal, pool1	10046-101G1	70.03	38.61	11.81	5.44	2.67	1.23	0.51	1.75	0.92
hepatic mesenchymal tumor cell line:LI90	10778-110G4	10.18	6.48	1.54	0.00	0.93	0.62	1.54	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	2.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	26.08	5.75	1.22	0.00	0.22	0.22	0.55	0.11	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	27.92	7.28	0.85	0.00	0.00	0.12	1.09	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	30.62	7.88	1.92	0.00	0.30	0.30	0.91	0.40	0.00
hepatoma cell line:Li-7	10484-107A7	29.69	8.34	0.56	0.00	0.11	0.56	0.78	0.33	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	16.18	2.81	0.80	0.00	0.10	0.10	0.20	0.10	0.00
hippocampus - adult, donor10196	10169-103B7	20.82	23.66	18.93	10.41	0.00	0.95	1.89	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	48.37	26.74	31.84	14.70	1.63	2.45	3.27	1.02	0.61
hippocampus, adult, donor10258	10374-105G5	21.41	20.91	11.45	10.46	0.50	2.49	0.50	1.99	1.00
hippocampus, newborn, donor10223	10363-105F3	20.80	20.44	24.67	5.99	0.00	2.47	0.70	1.76	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	12.21	1.22	1.22	0.00	0.61	0.00	0.61	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	17.48	2.16	1.18	0.00	0.00	0.00	0.98	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	18.53	1.52	2.29	0.25	0.00	0.00	0.76	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	15.22	3.38	2.82	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	19.62	3.87	2.07	0.00	0.00	0.00	1.55	0.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	17.46	4.18	1.90	0.00	0.00	0.00	0.38	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	12.26	4.67	3.50	0.00	0.29	0.00	1.17	0.00	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	18.96	7.76	5.82	0.00	0.00	0.00	1.29	0.43	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	14.18	5.84	4.17	0.00	0.42	0.00	0.42	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	21.55	5.21	2.84	0.00	0.24	0.00	0.71	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	24.11	8.52	5.14	0.00	0.48	0.16	1.45	0.48	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	20.87	7.41	4.71	0.00	0.67	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	20.03	1.72	0.63	0.00	0.47	0.00	0.47	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	12.28	0.98	0.49	0.00	0.00	0.00	0.98	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	9.60	0.87	1.75	0.00	0.00	0.87	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	20.05	4.39	1.72	0.00	0.00	0.00	0.38	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	17.88	3.92	3.05	0.00	0.44	0.00	0.44	1.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	14.99	2.00	2.00	0.00	0.50	0.00	0.00	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	16.96	6.78	3.58	0.00	0.57	0.19	1.32	0.19	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	15.01	8.64	3.18	0.00	0.45	0.45	1.36	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	15.98	8.46	5.01	0.00	0.31	0.00	0.31	0.31	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	15.68	8.17	3.76	0.00	0.00	0.16	1.31	0.16	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	19.74	8.71	4.06	0.00	0.87	0.00	1.74	0.58	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	17.64	8.07	2.09	0.00	0.60	0.00	1.49	0.60	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	19.77	1.48	0.92	0.00	0.18	0.00	1.11	0.18	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	16.83	1.71	1.14	0.00	0.00	0.00	0.86	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	11.84	0.00	0.00	0.00	0.00	0.00	0.41	0.00	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	16.20	3.52	1.76	0.00	0.00	0.00	2.11	0.35	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	17.10	2.53	2.85	0.00	0.00	0.00	0.63	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	16.95	3.63	1.51	0.00	0.30	0.00	0.00	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	18.62	9.83	2.59	0.00	1.55	0.00	1.03	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	15.28	9.96	1.33	0.00	0.00	0.00	0.66	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	15.91	6.16	3.59	0.00	0.26	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	20.45	9.46	2.56	0.00	1.02	0.26	2.05	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	24.23	9.09	3.03	0.00	0.76	0.76	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	19.16	8.40	5.71	0.00	0.67	0.34	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	21.98	2.66	1.21	0.00	0.00	0.00	0.48	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	20.05	2.67	1.34	0.00	0.00	0.45	0.89	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	22.44	1.95	0.98	0.00	0.00	0.49	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	14.98	3.97	2.44	0.00	0.00	0.00	1.53	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	3.25	0.00	0.00	0.00	0.00	0.00	6.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	13.90	3.31	0.00	0.00	0.33	0.00	0.99	0.33	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	21.89	10.40	3.28	0.00	0.55	0.00	0.55	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	16.28	6.88	3.26	0.00	0.00	0.00	0.36	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	9.25	4.63	2.85	0.00	0.00	0.00	0.36	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	16.71	2.39	1.19	0.00	2.39	0.00	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	20.18	6.77	3.66	0.00	0.41	0.14	0.68	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	14.28	5.12	2.16	0.00	0.00	0.00	0.54	0.00	0.00
immature langerhans cells, donor1	11904-125F5	41.89	24.46	2.42	0.00	2.66	4.36	1.70	1.70	2.42
immature langerhans cells, donor2	11905-125F6	51.49	53.86	7.92	0.00	3.96	6.34	2.38	1.58	3.96
insula, adult, pool1	10039-101F3	38.80	41.35	35.20	14.29	3.88	4.26	1.70	2.65	2.37
keratoacanthoma cell line:HKA-1	10791-110H8	66.33	58.85	5.85	0.00	1.95	5.53	0.33	2.60	0.00
kidney, adult, pool1	10017-101C8	45.56	17.92	4.11	1.10	2.50	1.90	0.50	0.50	3.20
kidney, fetal, pool1	10045-101F9	52.77	26.67	9.55	0.35	1.98	2.33	0.71	0.64	1.91
large cell lung carcinoma cell line:IA-LM	10509-107D5	6.11	4.54	0.28	0.00	0.57	0.00	0.00	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	18.11	9.82	0.69	0.00	0.69	0.14	1.24	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	14.50	6.42	0.18	0.00	1.28	0.00	0.18	0.18	0.00
left atrium, adult, donor1	10079-102A7	6.54	9.81	3.27	3.27	0.54	1.09	1.09	0.00	3.27
left ventricle, adult, donor1	10078-102A6	13.15	5.06	3.03	1.52	0.00	0.00	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	12.31	8.76	1.09	0.00	0.27	0.55	0.00	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	2.16	2.16	1.08	0.00	0.00	0.00	0.36	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	2.17	0.54	0.54	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	3.64	1.46	1.21	0.24	0.00	0.00	0.24	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	1.05	1.05	0.00	0.00	1.05	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	30.34	8.74	1.65	0.00	0.24	0.71	0.71	0.12	0.00
liposarcoma cell line:KMLS-1	10782-110G8	4.06	1.25	1.56	0.00	0.31	0.31	0.62	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	8.89	2.31	0.97	0.00	0.12	0.00	0.24	0.00	0.12
liver, adult, pool1	10018-101C9	43.92	11.67	0.97	5.83	1.62	2.76	0.00	0.32	0.32
liver, fetal, pool1	10086-102B5	40.45	9.41	3.76	0.94	0.00	0.00	0.94	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	36.46	32.08	9.62	1.75	0.87	1.75	1.02	1.60	1.75
locus coeruleus, adult, donor10252	10165-103B3	46.32	34.51	14.21	2.21	2.03	1.66	1.66	1.66	1.11
locus coeruleus, adult, donor10258	10375-105G6	16.65	14.67	10.44	0.56	2.26	1.69	2.82	1.97	0.28
locus coeruleus, newborn, donor10223	10362-105F2	15.98	9.25	2.10	0.84	0.42	0.42	1.68	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	27.82	7.89	0.55	0.00	1.11	0.28	0.55	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	0.00	0.69	1.38	0.00	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	13.05	13.58	0.00	0.00	1.19	0.53	0.40	0.13	0.00
lung, adult, pool1	10019-101D1	52.92	30.95	4.25	1.18	3.31	1.89	0.95	0.71	2.01
lung, fetal, donor1	10068-101I5	64.22	46.81	13.13	4.00	3.71	3.14	0.57	1.43	0.86
lung, right lower lobe, adult, donor1	10075-102A3	68.27	24.29	4.58	0.92	3.67	0.46	1.83	0.00	0.92
lymph node, adult, donor1	10077-102A5	46.86	28.40	2.84	1.42	1.42	0.95	4.73	0.47	1.89
lymphangiectasia cell line:DS-1	10727-110A7	51.51	8.33	1.75	0.00	0.66	0.44	0.66	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	83.31	19.62	1.51	0.00	0.15	0.45	2.41	0.60	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	17.84	13.59	0.00	0.00	2.55	1.70	0.00	0.85	0.00
mature adipocyte, donor1	12231-129F8	10.21	11.54	4.00	1.78	2.22	2.66	0.00	0.89	0.44
mature adipocyte, donor2	12232-129F9	14.32	12.04	3.53	2.91	1.25	2.91	0.00	0.42	1.45
mature adipocyte, donor3	12233-129G1	14.22	20.15	3.08	3.08	2.13	2.84	0.24	0.00	0.71
mature adipocyte, donor4	12234-129G2	27.37	26.32	5.53	2.11	3.95	2.11	1.05	1.05	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	24.54	8.34	2.38	0.00	0.71	0.24	0.00	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	22.56	27.07	24.82	18.05	1.13	3.38	4.51	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	41.56	31.45	29.61	36.78	3.13	2.57	1.47	1.10	3.49
medial frontal gyrus, adult, donor10258	10368-105F8	18.74	14.30	14.93	12.07	0.64	0.32	0.95	0.95	2.86
medial frontal gyrus, newborn, donor10223	10352-105E1	17.06	11.09	6.82	0.43	0.43	1.71	7.25	0.85	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	30.21	25.82	25.14	23.79	1.18	1.69	8.94	2.03	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	52.63	36.71	33.32	40.96	2.33	3.40	2.33	1.91	3.61
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	9.63	13.48	5.78	9.63	0.00	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	57.41	14.35	43.06	0.00	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	34.10	35.18	21.89	0.72	1.08	1.79	0.72	1.08	1.79
medulla oblongata - adult, donor10196	10174-103C3	16.87	18.82	5.84	1.30	1.95	0.65	0.00	1.30	0.65
medulla oblongata, adult, donor10252	10155-103A2	41.02	33.13	17.03	4.33	3.10	2.32	2.01	1.24	1.70
medulla oblongata, adult, pool1	10038-101F2	46.12	47.02	18.20	3.10	4.33	4.90	1.06	3.51	1.88
medulla oblongata, newborn, donor10223	10361-105F1	21.53	10.07	11.80	0.35	1.04	0.69	1.04	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	58.23	12.62	11.07	0.00	0.66	0.44	1.55	0.44	0.00
medulloblastoma cell line:ONS-76	10759-110E3	1.47	0.49	0.24	0.00	0.00	0.00	0.00	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	6.61	1.44	0.14	0.00	0.14	0.00	0.00	0.00	0.00
melanoma cell line:G-361	10465-106H6	20.09	10.04	0.27	0.00	0.81	0.54	0.81	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	19.36	4.88	0.36	0.00	0.72	0.00	1.27	0.00	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	117.19	19.39	8.81	0.00	0.00	0.88	5.29	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	174.46	28.51	7.26	0.78	1.30	1.56	5.44	2.07	2.85
mesenchymal precursor cell - adipose, donor1	11747-123G1	21.79	8.90	1.38	0.00	0.92	0.15	1.07	0.15	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	11.27	6.54	0.36	0.00	0.55	0.55	0.55	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	8.70	4.97	0.83	0.00	1.66	0.00	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	8.01	5.06	0.98	0.00	0.56	0.56	0.42	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	9.05	3.47	0.77	0.00	0.39	0.00	0.58	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	6.94	3.47	1.39	0.00	1.39	0.69	2.08	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	8.41	7.38	0.86	0.00	1.54	0.86	0.86	0.00	0.86
mesenchymal precursor cell - cardiac, donor2	11753-123G7	12.31	7.82	1.50	0.00	1.50	0.81	0.23	0.12	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	24.01	11.41	1.06	0.13	0.53	0.53	0.80	0.40	1.06
mesenchymal precursor cell - cardiac, donor4	11755-123G9	12.56	8.10	0.41	0.00	0.54	0.41	0.54	0.14	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	12.23	4.84	0.71	0.00	0.43	0.28	0.28	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	14.82	5.27	0.66	0.33	1.32	1.98	0.99	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	18.54	6.64	0.83	0.42	0.69	0.69	0.28	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	8.38	9.08	0.70	0.00	1.40	0.70	0.70	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	7.76	6.74	1.02	0.00	1.22	0.82	0.41	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	16.53	6.83	1.08	0.00	1.44	1.44	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	9.41	6.10	0.83	0.00	0.72	0.52	0.21	0.21	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	3.88	3.88	1.37	0.00	0.91	0.91	1.37	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	9.23	3.36	0.42	0.00	0.42	0.42	0.42	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	15.09	3.89	0.30	0.00	0.60	0.60	0.30	0.00	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.82	7.88	0.44	0.00	0.53	0.35	0.26	0.26	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	15.83	12.52	1.47	0.00	1.47	1.84	0.74	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	12.30	6.87	1.43	0.00	2.86	0.00	2.00	0.57	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	10.53	4.21	1.68	0.00	2.11	0.42	2.11	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	9.59	4.11	3.20	0.00	1.37	1.37	0.00	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	16.63	10.74	2.30	0.51	1.53	0.51	0.77	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	19.37	8.90	2.62	0.00	1.05	1.57	0.26	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	13.25	7.70	0.31	0.00	0.92	0.31	1.23	0.00	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	16.00	6.59	2.59	0.24	0.71	1.18	1.88	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	18.95	10.83	1.69	0.00	0.68	0.68	1.35	0.00	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	14.54	7.86	3.93	0.00	0.39	0.79	0.79	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	14.83	8.80	2.78	0.46	0.93	1.85	0.46	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	16.44	10.09	2.60	0.58	1.44	1.15	1.73	0.29	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	19.86	8.70	4.91	0.45	1.12	0.89	1.12	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	19.71	7.21	3.85	0.24	1.68	1.20	0.72	0.48	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	23.47	8.80	1.47	0.00	0.00	2.20	0.73	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	14.77	10.74	1.68	0.67	1.01	0.34	1.68	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	11.87	8.19	2.87	0.00	0.82	0.00	1.23	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	18.04	11.60	4.73	0.43	0.86	1.72	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	8.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	10.33	0.00	0.00	0.00	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	15.91	8.12	1.30	0.32	0.97	1.30	1.30	0.32	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	21.82	5.82	0.00	1.45	1.45	1.45	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	9.60	10.66	0.00	0.00	0.00	1.07	0.53	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	17.17	4.09	4.91	1.64	0.82	0.82	1.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	13.61	9.72	1.55	0.78	1.55	1.55	1.17	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	2.10	2.10	0.00	2.10	2.10	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	11.92	5.96	0.99	0.00	0.00	1.99	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	9.53	0.00	0.00	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	12.45	8.89	2.96	0.59	0.59	0.59	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	8.53	7.31	2.44	2.44	3.66	2.44	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	17.10	6.33	3.17	0.63	3.80	0.00	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	17.25	7.24	1.03	0.69	1.72	0.34	0.69	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	4.30	4.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	3.99	0.00	3.99	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	17.22	0.00	6.89	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	15.48	9.37	0.81	1.22	0.81	0.81	1.63	0.41	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	15.89	9.53	0.00	2.38	2.38	0.00	0.79	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	14.74	7.07	0.59	1.77	0.00	0.59	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	18.70	11.22	0.62	2.49	0.94	0.31	1.25	0.62	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	17.38	12.03	0.00	1.34	4.01	0.00	4.01	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	16.56	5.91	1.18	2.37	0.00	0.00	2.37	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	10.27	0.00	0.00	0.00	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	22.03	7.57	3.44	1.38	1.38	1.38	1.38	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	13.85	8.41	5.44	2.47	0.49	2.97	2.47	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	15.70	12.34	3.36	1.12	1.12	3.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	17.17	8.90	4.45	1.91	0.64	0.64	1.27	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	11.69	6.85	2.42	0.00	0.00	2.01	1.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	6.54	2.18	0.00	4.36	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	10.14	7.60	5.07	0.00	1.27	0.00	3.80	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	7.28	3.64	0.61	0.00	0.61	2.43	0.00	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	9.88	6.59	0.00	0.00	2.47	2.47	2.47	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	14.29	6.55	2.78	0.40	0.99	0.99	0.20	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	15.25	8.11	2.27	1.30	1.30	0.97	0.65	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	17.32	15.28	4.07	3.06	2.04	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	8.51	6.96	6.96	0.00	2.32	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	22.21	18.19	0.71	0.00	1.65	1.42	1.18	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	15.06	8.57	1.62	0.00	0.70	0.00	0.23	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	4.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	4.32	1.44	0.41	0.00	0.21	0.10	0.72	0.21	0.00
mesothelioma cell line:Mero-25	10850-111F4	32.00	10.89	2.04	0.00	0.45	0.68	1.13	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	16.14	6.11	0.98	0.00	0.24	0.73	0.49	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	6.20	2.66	0.44	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	30.22	12.35	2.10	0.00	1.05	0.26	0.53	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	16.43	5.31	2.53	0.00	0.00	0.51	0.51	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	13.66	11.80	2.48	0.00	1.45	0.83	1.66	0.21	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	13.58	7.79	1.16	0.00	0.17	0.50	0.66	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	3.98	2.17	0.36	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	14.69	5.98	1.02	0.00	0.68	0.34	0.51	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	21.12	6.11	3.31	0.00	1.27	1.02	2.04	0.25	0.00
mesothelioma cell line:No36	10857-111G2	3.59	3.91	2.28	0.00	0.33	0.00	0.33	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	7.59	2.98	0.27	0.00	0.27	0.27	0.00	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	83.10	26.10	0.77	0.00	1.73	1.73	3.45	0.00	1.92
migratory langerhans cells, donor2	11902-125F3	84.02	28.45	0.98	0.00	4.27	3.30	1.95	0.49	0.49
migratory langerhans cells, donor3	11903-125F4	94.41	20.10	2.51	0.00	3.05	1.62	2.51	0.18	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	6.53	2.29	1.63	0.00	0.98	0.00	0.65	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	7.84	2.76	0.64	0.00	0.42	0.00	1.27	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	66.79	29.31	0.19	0.00	1.33	2.47	1.14	0.95	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	35.11	6.65	2.96	0.37	0.37	0.00	1.85	0.00	0.37
myeloma cell line:PCM6	10474-106I6	25.89	15.22	0.20	0.00	2.97	1.19	0.40	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	2.54	1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	37.85	20.59	2.55	0.00	2.16	1.18	0.59	0.20	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	15.49	15.15	1.00	0.00	1.11	1.00	0.45	0.45	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	16.03	11.10	0.51	0.00	1.18	0.66	0.07	0.37	0.44
nasal epithelial cells, donor2	12227-129F4	38.09	20.98	6.07	0.00	2.21	1.66	0.55	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	54.75	15.64	5.06	0.23	0.00	0.46	1.38	0.46	0.00
neuroblastoma cell line:NB-1	10539-107G8	31.24	17.21	7.67	0.94	0.94	0.56	0.37	0.37	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	4.85	1.05	0.84	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	61.12	13.60	4.66	0.56	0.19	0.19	0.56	0.19	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	6.88	3.08	1.42	0.00	0.00	0.00	0.24	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	25.18	14.41	8.08	0.48	0.00	0.00	1.43	0.16	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	12.28	2.42	3.02	0.60	0.00	0.00	0.40	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	10.17	5.72	1.27	1.27	0.00	0.64	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	8.25	6.65	2.40	0.00	1.06	0.27	0.00	0.00	0.27
neutrophil PMN, donor1	12133-128D9	238.00	178.50	0.00	0.00	14.87	29.75	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	94.71	47.35	0.00	0.00	0.00	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	53.44	12.01	0.00	0.17	0.17	0.17	0.68	0.34	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	6.40	3.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	11.86	7.05	4.17	0.00	0.00	0.96	0.64	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	9.20	5.26	0.79	0.00	0.79	0.53	1.05	0.00	0.79
nucleus accumbens, adult, pool1	10037-101F1	34.68	40.87	28.22	10.31	2.53	2.81	0.94	2.34	1.31
occipital cortex - adult, donor10196	10172-103C1	30.91	37.09	22.66	30.91	0.00	2.06	0.00	2.06	2.06
occipital cortex, adult, donor10252	10163-103B1	55.55	39.18	34.35	38.91	2.15	2.42	2.15	1.61	3.76
occipital cortex, newborn, donor10223	10355-105E4	42.58	38.58	28.02	2.18	2.91	4.00	6.19	5.82	1.82
occipital lobe, adult, donor1	10076-102A4	29.39	27.81	24.93	13.38	2.89	3.67	0.52	2.10	3.15
occipital lobe, fetal, donor1	10073-102A1	33.90	27.46	9.44	0.00	0.43	0.86	1.29	0.43	0.00
occipital pole, adult, pool1	10036-101E9	36.90	35.01	27.36	16.40	2.60	3.31	0.95	3.07	4.42
olfactory region, adult	10195-103E6	26.37	27.32	16.81	16.43	1.34	1.53	1.53	0.76	0.76
optic nerve, donor1	10277-104E7	106.06	80.04	30.02	0.00	0.00	8.00	6.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	25.86	4.78	3.53	0.00	0.11	0.11	0.34	0.34	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	7.97	6.05	1.51	0.00	0.27	0.27	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	24.04	23.71	1.86	0.00	0.68	1.35	2.88	0.51	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	21.72	7.62	0.92	0.00	0.69	0.58	0.92	0.23	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	19.40	8.53	3.82	0.00	1.18	1.76	0.00	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	14.95	9.34	1.87	0.00	0.93	0.00	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	24.60	5.09	2.76	0.00	0.21	0.42	0.64	0.21	0.00
ovary, adult, pool1	10020-101D2	20.70	14.33	7.25	0.87	1.92	0.52	0.44	0.35	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	6.97	3.48	0.73	0.00	0.37	0.00	0.37	0.00	0.00
pancreas, adult, donor1	10049-101G4	44.21	16.93	4.70	2.82	0.00	0.00	0.94	0.94	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	16.49	4.75	0.56	0.00	0.56	0.28	0.28	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	13.97	8.18	1.36	0.00	0.17	0.34	1.70	0.17	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	26.49	10.60	1.49	0.00	1.16	0.66	0.33	0.50	0.00
paracentral gyrus, adult, pool1	10035-101E8	30.84	33.22	27.46	11.99	2.01	1.92	0.46	2.11	3.29
parietal cortex, adult, donor10258	10373-105G4	16.15	19.08	17.62	10.28	0.73	0.73	0.73	0.73	1.47
parietal lobe - adult, donor10196	10171-103B9	28.21	31.04	21.63	13.17	1.88	0.00	0.94	1.88	3.76
parietal lobe, adult, donor10252	10157-103A4	37.05	23.66	24.23	29.36	2.00	1.14	2.57	0.29	2.85
parietal lobe, adult, pool1	10034-101E7	35.86	41.15	29.96	17.62	3.97	3.00	0.88	1.94	3.61
parietal lobe, fetal, donor1	10072-101I9	30.06	22.31	11.64	0.00	0.00	0.00	2.91	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	28.41	35.89	22.06	0.75	0.75	2.62	4.86	5.23	1.12
parotid gland, adult	10199-103F1	22.82	15.42	3.08	0.62	1.85	1.23	1.85	0.00	0.00
penis, adult	10200-103F2	40.82	23.10	10.21	4.83	3.76	1.07	0.00	1.07	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	7.44	5.39	1.30	0.00	0.00	0.00	0.37	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	19.67	11.95	1.17	0.00	1.17	1.02	0.58	0.00	0.00
pineal gland - adult, donor10196	10179-103C8	3.87	1.29	3.87	1.29	0.65	0.65	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	8.88	2.37	4.15	1.18	0.59	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	6.27	3.14	3.76	1.25	0.00	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	15.18	6.07	6.07	8.09	0.00	1.01	2.02	1.01	2.02
pituitary gland, adult, donor10252	10162-103A9	32.83	10.42	6.78	19.80	1.56	0.00	0.00	0.52	3.13
pituitary gland, adult, donor10258	10378-105G9	10.21	5.96	1.70	10.21	0.00	0.85	0.00	0.85	2.55
placenta, adult, pool1	10021-101D3	16.88	8.71	2.58	0.11	0.86	0.75	0.65	0.32	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	50.59	7.55	1.06	0.00	0.26	0.40	1.99	0.40	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	20.23	8.40	1.71	0.00	0.93	0.47	0.47	0.16	0.00
pons, adult, pool1	10033-101E6	37.10	32.88	9.90	2.84	2.93	4.30	0.34	2.41	2.84
postcentral gyrus, adult, pool1	10032-101E5	34.61	36.88	26.50	14.82	1.83	3.49	1.22	2.35	3.92
promyelocytes/myelocytes PMC, donor1	12132-128D8	60.65	37.65	2.09	0.00	0.00	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	16.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	16.02	13.55	0.58	0.00	1.31	1.17	0.73	0.58	0.44
prostate cancer cell line:PC-3	10439-106E7	9.62	4.36	0.54	0.00	0.54	0.00	0.18	0.00	0.00
prostate, adult, pool1	10022-101D4	18.32	12.15	7.07	0.91	1.09	0.91	0.27	0.27	0.36
putamen, adult, donor10196	10176-103C5	21.25	29.98	24.55	24.31	0.94	0.24	1.65	0.24	0.24
putamen, adult, donor10252	10152-102I8	33.33	19.61	19.61	13.73	0.00	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	14.21	10.93	13.11	17.48	0.00	0.00	0.00	1.09	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	19.57	18.12	21.02	22.47	0.48	1.21	0.97	1.21	0.00
putamen, newborn, donor10223	10365-105F5	11.24	17.99	3.00	1.50	0.00	2.25	3.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	30.55	15.42	1.75	0.58	1.16	0.58	0.29	0.58	1.45
rectum, fetal, donor1	10067-101I4	20.86	13.91	8.35	0.00	1.39	1.39	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	7.00	5.30	1.27	0.00	0.64	0.42	0.00	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	2.49	7.46	0.00	0.00	0.41	0.00	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	21.27	20.08	11.73	2.29	1.59	0.89	0.80	1.39	1.69
retinoblastoma cell line:Y79	10475-106I7	13.77	4.16	1.04	0.00	0.00	0.26	0.52	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	7.13	1.11	0.86	0.00	0.00	0.00	0.12	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	28.40	9.00	1.12	0.00	0.00	0.56	0.28	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	8.34	1.52	0.76	0.00	0.00	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	24.76	29.13	1.94	1.46	1.62	1.46	2.27	0.49	0.00
salivary acinar cells, donor2	11772-123I8	56.59	47.78	5.23	0.96	2.62	2.89	4.41	1.79	0.00
salivary acinar cells, donor3	11773-123I9	47.01	42.37	3.31	1.32	0.66	1.99	0.66	1.99	0.66
salivary gland, adult, pool1	10093-102C3	16.59	6.86	5.72	0.57	0.57	3.43	0.57	0.57	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	11.63	4.55	0.42	0.00	0.34	0.34	0.25	0.00	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	8.82	4.70	0.24	0.00	0.47	0.00	0.35	0.00	0.00
seminal vesicle, adult	10201-103F3	30.69	15.34	11.11	2.12	1.59	3.17	0.53	0.00	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	37.65	23.32	3.64	0.00	1.70	4.37	2.19	0.24	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	16.86	6.54	0.75	0.00	0.25	0.75	0.50	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	22.08	4.01	5.02	0.00	1.00	0.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	37.61	9.40	2.01	0.00	0.40	0.13	1.34	0.13	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	38.13	18.02	1.99	0.00	0.66	1.33	0.33	0.44	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	32.39	14.06	1.42	0.00	2.32	1.16	1.03	0.26	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	8.51	6.38	0.71	36.18	0.00	0.71	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	14.51	6.96	3.96	6.00	1.08	0.24	0.00	0.12	0.12
skeletal muscle, fetal, donor1	10066-101I3	13.07	5.03	9.05	0.00	1.01	1.01	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	33.93	54.28	0.00	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	25.88	11.36	6.94	0.63	2.52	0.00	0.00	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	26.35	10.01	4.00	0.00	0.67	0.67	0.00	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	27.74	9.46	2.84	0.00	0.00	0.63	0.63	0.00	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	13.49	4.24	1.54	0.00	0.00	0.39	0.77	0.00	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	28.68	17.14	1.81	0.00	0.82	0.49	0.49	0.49	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	31.53	4.02	1.93	0.00	0.00	0.00	1.93	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	50.99	24.41	1.74	0.00	0.65	1.09	1.31	0.87	0.44
small intestine, adult, pool1	10024-101D6	70.83	45.63	5.14	1.19	8.84	8.96	1.19	1.55	4.66
small intestine, fetal, donor1	10064-101I1	29.24	13.27	4.91	0.00	1.72	1.47	1.97	0.49	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	26.16	21.03	1.54	0.00	1.54	0.51	2.05	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	13.96	9.82	8.53	1.03	1.03	0.26	0.78	0.26	0.52
somatostatinoma cell line:QGP-1	10781-110G7	20.37	17.96	1.34	0.00	0.80	0.80	0.27	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	30.97	34.41	11.24	2.52	1.61	1.15	3.44	1.15	0.46
spinal cord, adult, donor10252	10159-103A6	41.40	35.88	10.65	2.37	1.97	2.37	0.79	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	9.69	18.68	2.08	0.00	0.69	1.38	2.08	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	46.96	25.00	17.69	0.00	1.83	1.83	1.83	1.22	0.00
spinal cord, newborn, donor10223	10359-105E8	22.04	11.02	6.89	0.92	0.00	0.92	4.13	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	11.95	7.47	1.05	0.00	1.19	0.75	0.15	0.30	0.00
spleen, adult, pool1	10025-101D7	61.79	25.11	4.30	1.10	2.64	2.42	0.88	0.55	1.87
spleen, fetal, pool1	10044-101F8	73.34	34.48	8.10	0.48	2.38	2.22	1.11	1.03	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	39.02	6.31	1.55	0.00	0.72	0.31	0.93	0.10	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	13.86	15.57	1.52	0.00	2.09	0.38	0.19	0.38	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	9.78	3.49	1.05	1.40	1.05	0.00	1.05	0.00	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	9.38	1.56	0.78	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	8.22	1.58	1.46	0.00	0.11	0.23	0.23	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	13.13	3.81	2.12	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	13.54	6.35	0.42	0.00	0.42	0.42	0.00	0.00	0.42
stomach, fetal, donor1	10062-101H8	49.13	25.63	3.20	1.07	3.20	2.14	1.07	2.14	1.07
submaxillary gland, adult	10202-103F4	33.61	15.95	3.42	0.57	2.28	2.28	1.14	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	89.31	66.47	11.01	0.42	3.32	3.32	3.12	3.53	0.83
substantia nigra, adult, donor10258	10371-105G2	20.69	16.55	9.31	2.59	2.07	0.00	0.00	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	41.69	20.49	21.20	0.71	0.71	2.83	1.41	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	18.34	6.19	1.83	0.00	0.23	0.46	0.23	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	39.33	42.72	32.55	14.16	2.37	3.14	0.85	3.56	2.29
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	19.94	19.23	9.26	0.00	0.00	0.71	0.00	1.42	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	31.65	20.66	11.87	0.00	0.44	0.44	2.20	0.44	0.00
tenocyte, donor1	11763-123H8	16.06	11.52	2.44	0.00	1.75	0.35	1.05	0.00	0.35
tenocyte, donor2	11765-123I1	12.21	6.49	0.38	0.00	2.29	0.38	0.76	0.00	0.00
tenocyte, donor3	11768-123I4	9.64	10.01	2.59	0.00	1.85	0.74	2.22	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	28.72	3.23	2.72	0.00	0.00	0.00	0.85	0.34	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	6.32	1.23	0.31	0.15	0.15	0.00	0.15	0.00	0.46
teratocarcinoma cell line:PA-1	10807-111A6	13.33	0.93	1.70	0.00	0.00	0.15	0.31	0.15	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	13.96	3.55	1.78	0.00	0.38	0.00	0.51	0.38	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	22.69	3.40	1.89	0.00	0.00	0.38	0.38	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	40.46	25.41	1.85	0.00	0.98	1.42	0.98	1.64	2.18
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	15.31	1.63	1.95	0.00	0.00	0.00	0.98	0.65	0.00
testis, adult, pool1	10026-101D8	20.72	19.65	6.01	1.07	2.58	0.86	1.93	0.43	0.97
testis, adult, pool2	10096-102C6	22.55	12.63	11.73	2.26	1.35	0.90	2.71	0.90	0.45
thalamus - adult, donor10196	10168-103B6	69.55	62.93	3.31	5.52	0.00	3.31	2.21	5.52	0.00
thalamus, adult, donor10252	10154-103A1	97.83	69.86	21.10	10.31	3.13	5.63	4.06	2.50	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	36.95	24.63	16.94	3.08	1.54	9.24	0.00	1.54	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	20.75	10.87	9.22	2.80	1.65	0.99	1.15	1.15	0.82
thalamus, newborn, donor10223	10366-105F6	16.11	12.66	2.30	0.00	1.15	0.58	0.58	1.73	0.00
throat, adult	10209-103G2	30.21	22.97	6.49	8.99	3.00	3.50	0.25	1.75	0.25
throat, fetal, donor1	10061-101H7	27.42	17.06	6.40	0.00	0.91	1.22	1.52	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	0.99	0.79	1.39	0.40	0.00	0.00	0.20	0.00	0.00
thymus, adult, pool1	10027-101D9	277.96	57.16	4.87	0.60	0.70	1.19	6.86	2.49	0.80
thymus, fetal, pool1	10043-101F7	332.81	64.21	5.51	1.77	1.04	1.56	3.74	2.49	2.39
thyroid carcinoma cell line:KHM-5M	10776-110G2	27.66	10.77	0.40	0.00	1.06	0.53	0.80	0.13	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	15.92	8.80	2.51	0.00	1.54	1.54	0.56	0.14	0.00
thyroid, adult, pool1	10028-101E1	73.81	41.43	8.49	0.93	4.20	4.57	1.77	1.12	5.79
thyroid, fetal, donor1	10060-101H6	31.90	17.40	10.28	0.00	1.05	0.79	1.85	1.05	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	18.48	18.48	0.00	3.08	3.08	3.08	3.08	0.00	0.00
tongue, adult	10203-103F5	35.82	21.40	5.81	5.12	1.63	2.33	3.02	0.47	0.23
tongue, fetal, donor1	10059-101H5	19.70	9.85	3.15	0.79	2.36	1.18	0.00	0.39	0.39
tonsil, adult, pool1	10047-101G2	63.31	46.58	3.01	0.90	3.31	2.40	1.00	0.90	0.80
trachea, adult, pool1	10029-101E2	25.28	13.17	3.35	0.25	1.72	1.80	0.49	0.16	0.33
trachea, fetal, donor1	10058-101H4	23.47	17.70	4.62	1.15	0.38	0.38	0.77	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	8.50	5.31	0.35	0.00	1.42	0.00	0.00	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	10.64	4.05	1.11	0.00	0.20	0.00	0.30	0.00	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	25.70	10.97	0.78	0.00	0.63	0.31	0.31	0.00	0.00
tridermal teratoma cell line:HGRT	10694-109G1	3.81	3.81	1.90	0.00	1.90	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	31.32	16.34	2.20	0.00	1.52	1.69	0.34	0.51	0.34
umbilical cord, fetal, donor1	10057-101H3	18.78	25.04	8.35	0.00	0.00	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	18.94	17.23	6.83	0.34	1.54	1.54	1.02	0.68	0.00
uterus, fetal, donor1	10055-101H1	11.77	9.73	1.54	0.51	0.00	1.02	0.51	0.51	1.02
vagina, adult	10204-103F6	38.13	18.74	9.05	3.23	0.65	1.94	1.94	0.65	3.88
vein, adult	10191-103E2	70.80	33.76	8.99	4.38	1.75	2.85	3.51	1.32	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	33.11	10.15	1.34	0.00	0.00	0.00	0.53	0.00	0.00